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Omega-6 (ω-6) and omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) are 
known to have opposite effects on the inflammatory and carcinogenesis 
processes. In general, ω-6 PUFAs promote inflammation and tumor 
development, whereas ω-3 PUFAs possess anti-inflammatory as well as anti-
oxidative activity and enhance host immune response. 
In the present study, I investigated the protective effects of ω-3 PUFAs on 
experimentally induced inflammation and carcinogenesis using fat-1 transgenic 
mice harboring ω-3 desaturase gene capable of converting ω-6 to ω-3 PUFAs. 
The ω-3/ω-6 PUFA ratio was significantly higher in the dorsal skin of fat-1 mice 
than that in the wild-type (WT) C57BL/6 mice. fat-1 mice expressed heme 
ii 
oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase-1 and their mRNA 
transcripts to a greater extent than did WT mice, which was attributable to the 
elevated activation of nuclear factor erythroid-related factor 2 (Nrf2) 
responsible for upregulation of cytoprotective and stress-responsive proteins. 
Exposure to solar radiation, especially ultraviolet B (UVB), is the most 
prevalent cause of skin photocarcinogenesis. Upon single exposure to UVB 
(500 mJ/cm2) irradiation, fat-1 mice exhibited a significantly lower degree of 
skin inflammation and phototoxicity and the expression of the pro-
inflammatory enzyme, cyclooxygenases-2 (COX-2) as compared to those 
observed in WT mouse skin. The protection of fat-1 mice from UVB-induced 
skin inflammation was associated with decreased phosphorylation of signal 
transducer and activator of transcription 3 (STAT3), one of the major pro-
inflammatory transcription factors. 
To determine whether the elevated ω-3 PUFA level also protects against 
UVB-induced skin papillomagenesis, hairless fat-1−/− and fat-1+/− mice were 
generated by cross-breeding of male fat-1+/− transgenic mice with female SKH-
1 hairless mice. After repeated UVB irradiation (180 mJ/cm2) thrice a week for 
23 weeks, the incidence and the multiplicity of papillomas were markedly 
reduced in the fat-1+/− group as compared to the fat-1−/− group. Moreover, the 
expression of COX-2 and activation of STAT3 in papillomas from fat-1+/− mice 
were significantly lower than those found in UVB-irradiated fat-1−/− mice. 
In another study, I also found that an increased ω-3 PUFA tissue status in the 
fat-1 mice led to effective protection against inflammatory tissue injury in 
iii 
colitis induced by 2,4,6-trinitrobenzene sulfonic acid. The endogenous increase 
in ω-3 PUFAs in fat-1 mice lso attenuated lipid peroxidation (malondialdehyde) 
and protein oxidation (4-hydroxy-2-nonenal). The observed protection against 
inflammatory and oxidative tissue damages in the fat-1 mouse colon was 
associated with decreased nuclear factor kappa B (NF-B) activity and 
expression of COX-2 and with elevated activation of Nrf2 and expression of its 
target gene, ho-1. 
Taken together, these observations indicate that functional fat-1 potentiates 
cellular defense against experimentally induced inflammation and tumor 
development through elevated activation of Nrf2 and subsequent upregulation 
of cytoprotective gene expression as well as suppression of pro-inflammatory 
signaling mediated by STAT3 and/or NF-B. 
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Anti-inflammatory effects of ω-3 fatty acids: Implications 











Inflammation underlies both physiological and pathological processes. 
Physiological or acute inflammation has been largely considered as the body’s 
innate and adaptive immune responses triggered by divergent noxious stimuli 
and conditions (Medzhitov 2008). Upon infection and tissue injury, a distinct 
set of substances (e.g., cytokines, chemokines, lymphokines, lipid mediators, 
etc.) are released in inflamed sites, triggering recruitment of leuokocytes and 
subsequent inflammatory reactions. While self-limited acute inflammation is 
protective, the defects in resolving the inflammation at an early stage results in 
a failure to return to the tissue homeostasis. This can cause persistent 
inflammatory conditions implicated in various pathologic conditions, such as 
rheumatoid arthritis, obesity, diabetes, cardiovascular diseases, 
neurodegenerative disorders, etc (Ricciotti & FitzGerald 2011, Nathan & Ding 
2010). The emerging role of chronic inflammation that may occur as a 
consequence of failure to resolve acute inflammation in multistage 
carcinogenesis has been extensively explored at both cellular and molecular 
levels (Kundu & Surh 2012). 
Due to poor cost-effectiveness and side effects of current anticancer therapy, 
attention has been paid to preventive strategies, especially by use of natural 
products (Harnack et al. 1997, Beaglehole et al. 2011, Manca et al. 2012, Sher 
et al. 2011). Besides a plethora of adverse effects reported for some 
chemotherapeutic drugs (Monsuez et al. 2010, Monje & Dietrich 2012, 
Eschenhagen et al. 2011, Ihbe-Heffinger et al. 2013, Love et al. 1989), use of 
３ 
some anti-inflammatory agents for the purpose of cancer chemoprevention has 
been hampered by the abrupt finding of unpredictable serious side effects 
(Arber et al. 2006, Bertagnolli et al. 2006, Burn et al. 2011b, Burn et al. 2011a). 
Thus, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical 
practice for cancer chemoprevention has always been outweighed by the 
possibility of serious complications. Furthermore, some currently used anti-
inflammatory drugs were developed without appreciation of their potential 
impact in resolution, and proved to be resolution-toxic (Gilroy et al. 1999, 
Bannenberg et al. 2005, Serhan et al. 2007) whereas others, such as 
glucocorticoids (Coutinho & Chapman 2011), cyclin-dependent kinase 
inhibitors (Rossi et al. 2006) and aspirin (Serhan et al. 1995, Serhan 2007), 
possess proresolving actions. 
A wide spectrum of natural products, especially those present in dietary and 
medicinal plants, have potent anti-inflammatory properties and have been 
shown to prevent tumor occurrence in several organs of experimental animals 
and inhibit the growth of neoplastic cells (Kim et al. 2009b, Pan et al. 2009, 
Gupta et al. 2010, Neergheen et al. 2010, Bishayee et al. 2012). A large number 
of chemopreventive phytochemicals capable of inhibiting the inflammatory 
cascade are known to modulate various signaling pathways implicated in cancer 
initiation, promotion and progression (Kundu & Surh 2005, Khor et al. 2008). 
Additionally, interest in natural proresolving mechanisms has been 
heightened in recent years (Henson 2005, Luster et al. 2005, Serhan & Savill 
2005). Polyunsaturated fatty acids (PUFAs) are precursors of biologically 
４ 
active lipid mediators, including eicosanoids that play an important role in 
modulating pro-inflammatory and/or anti-inflammatory/proresolving processes. 
Arachidonic acid (AA), a key member of the -6 PUFAs, produces the 
eicosanoids that are essential mediators of inflammation (Calder 2006). These 
include prostaglandins, leukotrienes, and thromboxanes. Some pro-
inflammatory prostaglandins (e.g., PGE2) promote carcinogenesis and 
stimulate tumor growth, metastasis and angiogenesis (Wang & Dubois 2010a). 
However, eicosanoids and some other bioactive lipid mediators produced from 









Fig. 1-1. Differential roles of -6 and -3 PUFAs in inflammation and 












2. The health beneficial effects associated with -3 PUFAs 
One major dietary source of anti-inflammatory -3 PUFAs is fish oil containing 
eicosapentaenoic acid (EPA; C20:5) and docosahexaenoic acid (DHA; C22:6). 
Numerous studies have demonstrated the protective effects of dietary 
supplementation with EPA and DHA against pathogenesis of multi-organ 
cancer (Toriyama-Baba et al. 2001) as well as other ailments, including 
cardiovascular disorders (Holub & Holub 2004), retinal degenerations (Souied 
et al. 2013), and neurodegenerative diseases (Connor & Connor 2007). 
Mammals are unable to synthesize EPA and DHA, but they can be formed from 
the shorter-chain -3 PUFA, α-linolenic acid (C18:3) obtained from the plant 
diet through elongation and desaturation (Calder 2008). Recently, attention has 
focused on a group of endogenous bioactive lipid mediators derived from DHA 
because of their powerful proresolving as well as anti-inflammatory activities. 
Examples are resolvins, protectins and maresins which are generated during the 
spontaneous resolution phase of inflammation (Dalli et al. 2013, Serhan & 
Savill 2005). 
Recommendations for dietary intake of -3 PUFAs are often provided for 
the combination of EPA and DHA. Both have a similar spectrum of biological 
properties. However, several studies have reported differential effects of EPA, 
DHA and their metabolites on organization, fluidity and permeability of plasma 
membrane, modulation of signaling pathways related to cellular pro- or anti-
inflammatory mechanisms, leukocyte functions (e.g., phagocytosis, 
chemotactic response and cytokine production), endothelial cell functions, cell 
７ 
proliferation and differentiation, etc (Russell & Burgin-Maunder 2012, Ma et 
al. 2012, Gorjao et al. 2009). This may be attributable to the differences in their 
carbon backbone structure in terms of the length and the degree of unsaturation. 
While EPA has 20 carbon atoms and 5 double bonds (20:5), DHA has a longer 
chain of 22 carbon atoms and 6 double bonds (22:6). The higher degree of 
unsaturation in DHA, compared with EPA, is considered to yield greater proton 
selectivity and conductance by increasing the membrane permeability in planar 
phospholipid bilayer preparations (Gorjao et al. 2009). Such structural 
differences may also contribute to different potency of DHA and EPA in 
modulating cellular inflammatory and anti-inflammatory/proresolving 
processes. Under certain experimental conditions, DHA was shown to be more 
effective than EPA in terms of anticancer effects (Serini et al. 2011) and 
capability of decreasing blood pressure, heart rate, and platelet aggregation 
(Cottin et al. 2011, Ibrahim et al. 2011). Fig. 1-2 illustrates the various health 
benefits that can be achieved by DHA intake. Transcription factors have also 
been proposed as molecular targets of DHA in exerting its anti-inflammatory 







Fig. 1-2. The health beneficial effects associated with DHA derived from 







Fig. 1-3. Effects of some DHA-derived bioactive species on activation of 
representative transcription factors involved in pro-/anti-inflammatory 
signaling. 15-Lipoxygenase (15-LOX) transforms DHA into 17S‐
hydroperoxy‐DHA, which is converted into RvD1 by 5-LOX activity of 
neighbouring leukocytes. Some electrophilic species (e.g., 4-HHE and 17-oxo-
DHA) formed through peroxidation or oxidative metabolism of DHA activate 
Nrf2-mediated anti-inflammatory signaling. They can also inhibit pro-
inflammatory transcription factors including NF-κB. The roles for these 
reactive species in the resolution of inflammation are largely elusive. Adopted 




3. The fat-1 transgenic mouse 
An appropriate animal model that can eliminate confounding factors of diet has 
been delevoped for precise evaluation of the health effects of -3 PUFAs. 
Mammals normally lack the enzyme that can convert -6 to -3 PUFAs. 
However, Caenorhabditis elegans and some other lower life animas harbor a 
gene called fat-1 (Spychalla et al. 1997). fat-1 gene encodes an -3 fatty acid 
desaturase that can introduce a double bond into -6 PUFAs at the -3 position 
of their hydrocarbon chains to form -3 counterparts (Kang et al. 2001, 2007). 
Kang et al. generated a transgenic mouse capable of converting -6 to -3 fatty 
acids with the fat-1 gene (Kang et al. 2004, 2007 ; see Fig. 1-4 for illustration). 
This will eliminate the need of two different diets for a comparative study so 
that the potential variations of the impurities, flavor, caloric and other 
components in the supplemented oils can be avoided. Both transgenic and wild-
type (WT) mice are maintained on just a single diet rich in -6 PUFAs, mainly 
linoleic acid (LA) with very little -3 PUFAs. Under this dietary regime, WT 
mice have little or no -3 fatty acid in their tissues because they cannot 
naturally produce -3 from -6 PUFAs, whereas the fat–1 transgenic mice have 
significant amounts of -3 PUFAs derived from -6 PUFAs in their tissues 
(Kang et al. 2004, 2007). This -3 rich profile of lipid with a balanced ratio of 
-6 to -3 can be observed in all of the organs and tissues, without changing 





Fig. 1-4. Generation of fat-1 transgenic mice expressing the gene encoding 









STATEMENT OF PURPOSE 
 
Inflammation is closely linked to oxidative stress in the pathogenesis of cancer 
and many other human ailments. The majority of health beneficial effects of -
3 fatty acids have been ascribed to its anti-inflammatory as well as anti-
oxidative properties, but the underlying molecular mechanisms, particularly in 
relation to their chemopreventive potential, remain largely elusive. 
The modulation of the intracellular signal transduction involved in aberrant 
induction of pro-inflammatory enzymes is considered as a rational approach for 
chemoprevention. A detailed understanding of the signaling network involved 
in an inappropriate expression of pro-inflammatory enzymes in ultraviolet B 
(UVB)-induced inflammation, photocarcinogenesis and 2,4,6-trinitrobenzene 
sulfonic acid (TNBS)-stimulated colitis is yet to be elucidated. 
The purpose of the present study was to investigate whether an increased ω-
3 fatty acid tissue level in fat-1 mice protects against experimentally induced 
disease models and to elucidate the molecular mechanisms underlying cellular 
adaptive or defensive response to pro-inflammatory and oxidative damages by 











The increased ω-3 fatty acid tissue level in fat-1 
mice protects against UVB-induced inflammatory and 











Exposure to solar radiation, especially ultraviolet B (UVB), is the main cause 
of photocarcinogenesis. Omega-3 (ω-3) polyunsaturated fatty acids (PUFAs), 
which occur at high levels in some fish oils, are known to scavenge lipid 
peroxyl radicals and increase host immunoresponsiveness. As UVB-induced 
oxidative stress and oxidative stress–mediated inflammation have been 
implicated in photocarcinogenesis, this study was designed to investigate the 
anti-inflammatory and anti-oxidative capacity of ω-3 PUFAs using fat-1 
transgenic mice that are capable of converting ω-6 to ω-3 PUFAs. Wild-type 
(WT) C57BL/6 mice and fat-1 mice were maintained on the AIN-93 diet 
supplemented with 10% safflower oil rich in ω-6 PUFAs for 5 weeks. The ω-
6/ω-3 PUFA ratio was significantly lower in the dorsal skin of fat-1 mice than 
that in the WT mice. Upon single exposure to UVB (5.0 kJ/m2) radiation, WT 
mice showed higher degree of skin inflammation, phototoxicity, and the 
expression of pro-inflammatory enzymes, cyclooxygenases-2 and inducible 
nitric oxide synthase, which were significantly decreased in fat1 mouse skin. 
The protection of fat-1 mice from UVB-induced skin inflammation resulted 
from decreased phosphorylation of signal transducer and activator of 
transcription 3 (STAT3) and Akt. In comparison to WT animals, higher levels 
of cytoprotective proteins, such as heme oxygenase-1 and NAD(P)H:quinone 
oxidoreductase-1, were found in skin of fat-1 mice. Furthermore, the elevated 
activation of nuclear factor erythroid-related factor 2 (Nrf2), which regulates 
１５ 
transcriptional activation of cytoprotective proteins and hence protects against 
inflammatory and oxidative responses, was observed in the fat-1 mouse skin. 
In conclusion, these results show that fat-1 gene confers a protective effect 
against UVB-induced inflammatory and oxidative skin damages through 
elevation of endogenous ω-3 PUFA production and Nrf2-mediated upregulation 
of cytoprotective gene expression in mouse skin. 
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Ultraviolet B (UVB) radiation is an important environmental factor responsible 
for the pathogenesis of skin aging and photocarcinogenesis (Afaq et al. 2005, 
Halliday 2005). Excessive exposure to UVB causes a variety of adverse skin 
reactions, such as erythema, edema, sunburn, hyperplasia, inflammation and 
immunosuppression (Afaq et al. 2005, Halliday 2005, Yaar & Gilchrest 2007, 
Matsumura & Ananthaswamy 2004). Multiple lines of evidence suggest that 
UVB exerts its detrimental effect mainly through generation of reactive oxygen 
species (ROS) (Cerutti et al. 1994, Del Prete et al. 2011) causing oxidative 
modification of cellular macromolecules and increasing accumulation of lipid 
peroxidation products, such as 4-hydroxynonenal (4-HNE) and 
malondialdehyde (MDA) (Oberley et al. 2004, Petersen & Doorn 2004, Tyrrell 
1995). In addition, UVB exposure impairs the antioxidant defense system by 
decreasing the activity of various antioxidant enzymes (Sander et al. 2004). The 
UVB-induced oxidative stress triggers epidermal inflammation through 
inappropriate modulation of intracellular signaling pathways, thereby 
predisposing skin cells to carcinogenesis (Katiyar et al. 1999) and increasing 
the risk of skin carcinogenesis (Halliday 2005). As UVB-induced oxidative 
stress triggers photo-inflammation and photocarcinogenesis, the optimal 
maintenance or potentiation of antioxidant defense capacity can help protect 
against oxidative damage, covalent modification, inflammatory injury and 
tumor development caused by UVB. 
１７ 
Two representatives of pro-inflammatory enzymes, cyclooxygenase-2 
(COX-2) (Kundu et al. 2008, Tripp et al. 2003) and inducible nitric oxide 
synthase (iNOS) (Chang et al. 2011) are overexpressed aberrantly in the 
epidermis upon exposure to UVB radiation. Whereas cox-2 transgenic mice are 
prone to develop experimentally induced skin tumors (Muller-Decker et al. 
2002), genetic ablation of cox-2 protects animals against skin papillomagenesis 
(Tiano et al. 2002). Likewise, mice genetically deficient in inos are relatively 
less susceptible to phorbol ester-induced skin inflammation (Medeiros et al. 
2009), and pharmacological inhibition of iNOS decreases the multiplicity of 
chemically induced papilloma formation (Chun et al. 2004). Since abnormally 
elevated COX-2 (An et al. 2002, Fischer et al. 2007) and iNOS (Chun et al. 
2004) expression has been frequently observed in murine and human 
nonmelanoma skin cancers, the COX-2 and iNOS signaling pathways are 
considered as a potential target for achieving chemoprevention against 
photocarcinogenesis. 
The expression of COX-2 (Koon et al. 2006) and iNOS (Lo et al. 2005, 
Ziesche et al. 2007) is regulated by an eukaryotic transcription factor, signal 
transducer and activator of transcription 3 (STAT3). Previous studies have 
demonstrated that UVB irradiation activates STAT3 in mouse skin (Kim et al. 
2009a). Furthermore, transient levels of ROS can activate cellular proliferation 
or survival signaling pathways, including the phosphoinositide-3-kinase–
protein kinase B/Akt (PI3K-PKB/Akt) pathway. The aberrant expression of 
COX-2 and iNOS in UVB-irradiated cultured cells as well as in mouse skin in 
１８ 
vivo results, at least in part, from the inappropriate amplification of intracellular 
signaling pathways comprising upstream kinase PI3K/Akt (Tang et al. 2001b, 
Carpenter & Cantley 1996). Therefore, interference with the signaling cascades 
mediated by these upstream regulators may block aberrant overexpression of 
COX-2 and iNOS, thereby ameliorating UVB-induced skin inflammation and 
oxidative damages. 
On the other hand, cellular redox homeostasis is maintained by the 
constitutive induction of cytoprotective genes that encode distinct set of anti-
oxidative and other cytoprotective proteins such as heme oxygenase-1 (HO-1) 
and NAD(P)H:quinone oxidoreductase-1 (NQO1) (Nguyen et al. 2005). The 
induction of these cytoprotective proteins can confer protection against 
oxidative stress and inflammation, thereby preventing the development of 
cancer (Kundu & Surh 2010). HO-1 and NQO1 knockout mice were more 
prone to skin tumor development (Was et al. 2011, Long et al. 2001). The robust 
induction of aforementioned cytoprotective proteins is known to be mediated 
by nuclear factor erythroid-related factor 2 (Nrf2) (Surh et al. 2008). Thus, one 
of the potential strategies to prevent skin tissue damages and related abnormal 
disorders is to enhance the Nrf2-mediated induction of cytoprotective gene 
expression. 
There is competition between ω-6 and ω-3 polyunsaturated fatty acids 
(PUFAs) for the same metabolic enzymes. The availability of ω-6 and ω-3 
PUFAs and their ratio in cellular lipids determine the cellular eicosanoid 
profiles. A balanced ω-6/ω-3 PUFA ratio of body lipids is essential for normal 
１９ 
growth and development and plays an important role in prevention as well as 
treatment of many clinical problems (Simonsen et al. 1998, Gago-Dominguez 
et al. 2003, Maillard et al. 2002, Xia et al. 2005). Transgenic fat-1 mice 
expressing the fat-1 gene derived from Caenorhabditis elegans, are capable of 
producing ω-3 PUFAs from ω-6 PUFAs and thereby maintain a balanced ratio 
of ω-6/ω-3 PUFAs in their tissues and organs (Kang et al. 2004). In the present 
study, fat-1 mice also show a marked increase in ω-3 PUFAs and decrease in 
ω-6 PUFAs, exhibiting a lower ω-6/ω-3 PUFA ratio in their skin tissues. This 
prompted me to investigate an impact of an enhanced ω-3 PUFA tissue status 












3. Materials and Methods 
Animals and diets 
Male transgenic fat-1 mice (Kang et al. 2004) were backcrossed female mice 
with wild-type (WT) C57BL/6 background (Charles River Laboratories, 
Wilmington, MA). Animals were kept in standard cages under specific 
pathogen-free conditions. Each cage housed age and weight-matched mice, 
combining one WT and one fat-1 transgenic mouse. They were fed a special 
diet (10% safflower oil), high in ω-6 and low in ω-3 PUFAs. All studies were 
approved by the Institutional Animal Care and Use Committee at Seoul 
National University. The offsprings were determined by genotyped for fat-
1+/− heterozygosity using the Tissue-DirectTM PCR Kit (Lamda Biotech, Inc. St. 
Louis, MO). The genotyping primers of fat-1 were as follows: fat-1, 5’-CTG 
CAC CAC GCC TTC ACC AAC C-3’ (forward) and 5’-ACA CAG CAG CAG 
ATT CCA GAG ATT-3’ (reverse). In this study, transgenic fat-1 mice used were 
female heterozygous. 
 
Analysis of fatty acid composition 
Fatty acid profiles were investigated using gas chromatography as described 
previously (Kang & Wang 2005). Briefly, fresh skin tissues were grounded to 
powder under liquid nitrogen and subjected to extraction of total lipids and fatty 
acid methylation by heating at 100°C for 1 h under 14% boron trifluoride-
methanol reagent. Fatty acid methyl esters were analyzed by gas 
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chromatography using a fully automated Agilent 7890A system (Agilent, Santa 
Clara, CA) equipped with a flame-ionization detector. Peaks of resolved fatty 
acids were identified by comparison with the fatty acid methyl ester reference 
standard (Sigma Aldrich, St. Louis, MO), and area percentage for all resolved 
peaks was measured by using the ChemStation software (Agilent Technologies, 
Palo Alto, CA). 
 
Source of UVB radiation 
The dorsal hair of haired mice was trimmed 2 days before exposure to UVB 
radiation. The UVB radiation source was a 5×8 Watt tube, which emits an 
energy spectrum with high fluency in the UVB region (with a peak at 312 nm). 
A Biolink BLX-312 UV crosslinker (Vilbert Lourmat, Marne-la-Valle´ e, 
France) was used to irradiate mouse skin (5.0 kJ/m2 dose of UVB). 
 
Hematoxylin and eosin (H&E) staining and terminal deoxynucleotidyl 
transferase dUTP nick-end labeling (TUNEL) assay 
The skin was removed from euthanized mice at 24 h after UVB exposure. 
Sections of harvested mouse skin were fixed with 10% neutral buffered 
formalin and embedded in paraffin. Mounted sections (4 μm) were stained with 
H&E for light microscopy. Apoptotic cells were detected in paraffin-embedded 
skin sections by the TUNEL assay with the ApopTag® peroxidase in situ 
apoptosis detection kit (Millipore, Billerica, MA). The apoptotic cells were 
visualized by light microscopy. 
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Immunohistochemical analysis (IHC) 
The dissected skin was prepared for IHC of the expression patterns of 4-HNE- 
or MDA-modified protein, COX-2, P-STAT3 (Tyr705) and Nrf2. Four-μm 
sections of 10% formalin-fixed, paraffin-embedded tissues were cut on 
silanized glass slides, deparaffinized three times with xylene and rehydrated 
through graded alcohol bath. The deparaffinized sections were heated by using 
microwave and boiled twice for 6 min in 10 mM citrate buffer (pH 6.0) for 
antigen retrieval. To diminish nonspecific staining, each section was treated 
with 3% hydrogen peroxide and 4% peptone casein blocking solution for 15 
min. For the detection of respective protein expression, slides were incubated 
with proteins modified with 4-HNE or MDA (JaICA, Nikken SEIL Co. Ltd., 
Shizuoka, Japan), COX-2 (Cayman Chemical Co., Ann Arbor, MI), P-STAT3 
(Cell Signaling Technology, Beverly, MA) and Nrf2 (Santa Cruz Biotechnology, 
Inc., Santa Cruz, CA) antibodies at room temperature for 40 min in Tris-
buffered saline containing 0.05% Tween 20, and then developed using 
horseradish peroxidase-conjugated secondary antibodies (rabbit or mouse; 
Dako, Glostrup, Denmark). The peroxidase binding sites were detected by 
staining with 3,3’-diaminobenzidine tetrahydrochloride. Finally, 
counterstaining was performed using Mayer’s hematoxylin. 
 
Tissue lysis and protein extraction 
The UVB irradiated dorsal skin was collected and fat was removed on ice to 
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get the epidermis. Collected epidermis was homogenized in an ice-cold lysis 
buffer [150 mM NaCl, 0.5% Triton-X 100, 50 mM Tris–HCl (pH 7.4), 20 mM 
ethylene glycol tetra-acetic acid, 1 mM dithiothreitol (DTT), 1 mM Na3VO4 
and protease inhibitors, 1 mM phenylmethyl sulfonylfluoride (PMSF) and 
ethylenediaminetetraacetic acid (EDTA)-free cocktail tablet] followed by 
periodical vortex for 30 min at 0°C. The lysates were centrifuged at 14,800 g 
for 15 min at 4ºC. The supernatants were collected and stored at -70°C until use. 
 
Fractionation of cytosolic and nuclear extracts 
Scraped dorsal skin of mice was homogenized in 800 μL of hypotonic buffer A 
[10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 7.8), 
1.5 mM MgCl2, 10 mM KCl, 1 mM DTT, 0.1 mM EDTA and 0.1 mM PMSF]. 
To the homogenates was added 80 μL of 10% Nonidet P-40 (NP-40) solution, 
and the mixture was then centrifuged for 15 min at 14,800 g. The supernatant 
was collected as a cytosolic fraction. The precipitated nuclei were washed once 
with 500 μL of buffer A plus 50 μL of 10% NP-40, centrifuged, resuspended in 
200 μL of buffer C [50 mM HEPES (pH 7.8), 50 mM KCl, 300 mM NaCl, 0.1 
mM EDTA, 1 mM DTT, 0.1 mM PMSF and 20% glycerol] and centrifuged for 
15 min at 14,800 g. The supernatant containing nuclear proteins was collected 
and stored at -70°C until use. 
 
Western blot analysis 
For Western blot analysis, the total protein concentration was quantified by 
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using the bichinconinic acid protein assay kit (Pierce, Rockford, IL). Cell 
lysates (30 μg protein) were mixed and boiled in sodium dodecyl sulfate (SDS) 
sample buffer for 5 min before 8-15% SDS–polyacrylamide gel electrophoresis 
(SDS-PAGE). They were separated by SDS-PAGE and transferred to a 
polyvinylidene difluoride (PVDF) membrane (Gelman Laboratory, Ann Arbor, 
MI). The blots were blocked in 5% fat-free dry milk in tris-buffered saline 
containing 0.1% tween 20 (TBST) for 1 h at room temperature. The membranes 
were incubated for 12-24 h at 4°C with dilutions of primary antibodies for 
proteins modified with 4-HNE (JaICA, Nikken SEIL Co. Ltd., Shizuoka, Japan), 
actin (Sigma Aldrich, St. Louis, MO), COX-2 (Cayman Chemical Co., Ann 
Arbor, MI), iNOS (BD Biosciences, San Jose, CA), P-STAT3 (Tyr705), STAT3, 
P-Akt (Ser473), Akt (Cell Signaling Technology, Danvers, MA), lamin B 
(Invitrogen, Carlsbad, CA), HO-1 (Stressgen Biotechnologies Co., San Diego, 
CA), NQO1 (Abcam Inc., Cambridge, MA) and Nrf2 (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA). Membranes were washed followed by 
incubation with 1:3000 dilutions of respective horseradish peroxidase 
conjugated secondary antibodies (rabbit or mouse; Zymed Laboratories Inc., 
San Francisco, CA) for 2 h and again with TBST. Protein expressed was 
visualized with an enhanced chemiluminescent (ECL) detection kit (Amersham 
Pharmacia Biotech, Buckinghamshire, UK) and LAS-4000 image reader 
(Fujifilm, Tokyo, Japan) according to the manufacturer’s instructions. 
 
Reverse transcription-polymerase chain reaction analysis (RT-PCR) 
２５ 
Total RNA was isolated from mouse skin tissues using TRIzol® reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. To 
generate the cDNA from RNA, 1 µg of total RNA was reverse transcribed with 
murine leukemia virus reverse transcriptase (Promega, Madison, WI) for 50 
min at 42°C and again for 15 min at 72°C. About 1 μl of cDNA was amplified 
with a PCR mixture (HS Prime Taq 2X Premix, Daejeon, South Korea) in 
sequential reactions. The primers used for each RT-PCR reactions are as follows: 
cox-2, 5’-CTG GTG CCT GGT CTG ATG ATG-3’ and 5’-GGC AAT GCG 
GTT CTG ATA CTG-3’; actin, 5’-AGA GCA TAG CCC TCG TAG AT-3’ and 
5’-CCC AGA GCA AGA GAG GTA TC-3’; ho-1, 5’-TAC ACA TCC AAG 
CCG AGA AT-3’ and 5’-GTT CCT CTG TCA GCA TCA CC-3’; nqo1, 5’-TCG 
GAG AAC TTT CAG TAC CC-3’ and 5’-TGC AGA GAG TAC ATG GAG 
CC-3’; nrf2, 5’-CCT CTG TCA CCA AGC TCA AGG-3’ and 5’-TTC TGG 
GCG GCG ACT TTA TT-3’ (forward and reverse, respectively). Amplification 
products were analyzed by 2-3% agarose gel electrophoresis, followed by 
staining with SYBR Green (Invitrogen, Carlsbad, CA) and photographed using 
fluorescence in LAS-4000 (Fujifilm, Tokyo, Japan). 
 
Statistical analysis 
All the values were expressed as the mean ± standard error (SE) of at least three 
independent experiments. Statistical significance was determined by the 
Student’s t-test and p <0.05 was considered to be statistically significant. 
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4. Results 
fat-1 transgenic mice had higher amounts of ω-3 PUFAs in skin tissues as 
compared to those of WT mice 
The fat-1 gene of C. elegans encodes an ω-3 fatty acid desaturase enzyme that 
converts ω-6 PUFAs to ω-3 PUFAs (Kang 2007). We performed gas 
chromatography to determine an effect of fat-1 transgene on fatty acid profiles 
of their skin (Fig. 2-1). Both WT and fat-1 transgenic mice born to the same 
mother were fed an identical diet that was high in ω-6 PUFAs, but deficient in 
ω-3 PUFAs. During this dietary regime, the fat-1 mice had significantly higher 
amounts of ω-3 fatty acids, particularly docosahexaenoic acid (DHA) in skin 
tissues as compared to those of WT mice. However, the reduction of ω-6 fatty 
acids was not as dramatic as increases in ω-3 fatty acids. The results showed a 
decrease in ω-6/ω-3 fatty acid ratio (18:2n-6 + 18:3n-6 + 20:3n-6 + 20:4n-
6)/(18:3n-3 + 20:3n-3 + 20:5n-3 + 22:6n-3) in the skin from fat-1 mice (Table 
2-1 and Fig. 2-1C). 
 
UVB-induced inflammation and oxidative stress were attenuated in fat-1 
mice compared with those in WT mice 
Exposure to UVB radiation induces skin hyperplasia and apoptosis as a 
consequence of inflammatory tissue injury (Halliday 2005). As illustrated in 
Fig. 2-2A, UVB-induced skin inflammation was less severe in fat-1 transgenic 
mice than that in WT mice upon exposure to UVB (5.0 kJ/m2 radiation) for 24 h. 
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The results showed a dramatic attenuation of the skin hyperplasia in the fat-1 
mice. Fig. 2-2A also represents results of an independent study comparing the 
extent of apoptosis in the mouse skin. The UVB-exposed fat-1 mice had less 
apoptotic epidermal cells than the UVB-exposed WT mice. UVB irradiation 
produces ROS, which leads to lipid peroxidation (Sander et al. 2004, Halliday 
2005) and photodamage (Tyrrell 1995). 4-HNE and MDA are two 
representative lipid peroxidation products (Oberley et al. 2004, Petersen & 
Doorn 2004). The levels of 4-HNE and MDA-modified proteins were much 
lower in the skin from fat-1 mice than those from WT animals upon UV 
irradiation (Fig. 2-2A and B). 
 
UVB-induced expression of COX-2 and iNOS was decreased in the skin of 
fat-1 mice as compared to that in the WT mouse skin 
According to previous studies, irradiation with UVB induced the abnormal 
expression of two representative pro-inflammatory enzymes, COX-2 (Kundu 
et al. 2008) and iNOS (Chang et al. 2011), in mouse skin. To assess whether 
the fat-1 transgene-mediated protection against UVB-induced inflammation 
involves alteration in the expression of pro-inflammatory enzymes, skin tissue 
samples were subjected to immunoblot analysis to detect their levels. UVB-
induced expression of COX-2 and iNOS was increased significantly in the WT 
mouse skin, but this was markedly reduced in the skin of fat-1 mice (Fig. 2-
3B). Immunohistochemical analysis further confirmed the inhibitory effect of 
endogenously produced ω-3 fatty acids on UVB-induced COX-2 expression in 
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the fat-1 mouse skin (Fig. 2-3C). In unirradiated WT and fat-1 mice, specific 
COX-2 immunostaining was barely detectable in the mouse skin. In response 
to UVB exposure, the number of COX-2 positive cells increased in the WT 
mouse skin; however, an elevated ω-3 PUFA production attenuated UVB-
induced COX2 expression in the fat-1 mouse skin. 
 
UVB-induced phosphorylation of STAT3 and Akt was diminished in the fat-
1 mouse skin compared with that in the WT mouse skin 
The protein expression of COX-2 and iNOS is transcriptionally regulated by 
ubiquitous eukaryotic transcription factors. Since, STAT3 is the one of the 
representative transcription factors known to regulate COX-2 (Koon et al. 2006) 
and iNOS expression (Lo et al. 2005, Ziesche et al. 2007), activation of the 
aforementioned transcription factor in the UVB-stimulated mouse skin was 
assessed. The phosphorylation of STATs at the tyrosine 705 residue has 
generally been accepted as a prerequisite for their DNA binding and 
transactivation (Ramsauer et al. 2002). We determined the level of 
phosphorylated as well as total STAT3 protein in the mouse skin using 
monoclonal antibodies. The total STAT3 levels remained unchanged during 
these events. As illustrated in Fig. 2-4A, exposure of the fat-1 mice to UVB 
radiation resulted in a significant inhibition of STAT3 phosphorylation at the 
tyrosine 705 residue. In addition, Western blot analysis with nuclear extract 
from skin tissues showed UVB induced nuclear translocation of phosphorylated 
STAT3, which was blunted in the fat-1 mice. A significantly lower level of 
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phospho-STAT3 (Tyr705), an activated form of STAT3, in the skin from fat-1 
mice was verified by immunohistochemical analysis (Fig. 2-4B). Bito et al. 
have suggested that STAT3 activation is one of the initial events in UV-exposed 
human skin along with ROS generation and apoptotic cell death (Jean et al. 
2007). There are several pathways by which keratinocytes might protect 
themselves from apoptosis. The PI3K/Akt signaling pathway is thought to be 
initiated and prolonged by ROS release in response to UVB irradiation (Zhang 
et al. 2001). Our data showed that UVB caused significant phosphorylation of 
Akt at Ser473 whereas the total Akt levels remained unchanged (Fig. 2-4A). A 
significant decrease in the levels of phosphorylated Akt was noted, which is 
attributable to an increased ω-3 fatty acid level in the skin of fat-1 mice. 
 
The Nrf2-mediated induction of cytoprotective gene expression was elevated 
in the skin of fat-1 mice 
Oxidative stress plays a major role in the induction and progression of 
inflammation and its level depends on the balance between ROS production 
and cytoprotective protein expression (Kundu & Surh 2010). The Nrf2-
mediated induction of HO-1 and NQO1 expression was significantly increased 
in the skin of fat-1 mice as compared to that of WT mice (Fig. 2-5A and B). 
There was a slight increase in the expression of Nrf2 was seen in the fat-1 
mouse skin (Fig. 2-5B and C), but more pronounced enhancement was 
observed in nuclear translocation of Nrf2 in the skin tissue from fat-1 mice (Fig. 
2-5B). However, there was no difference found in the Nrf2 mRNA level in the 
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skin between WT and fat-1 mice (Fig. 2-5A). This result indicates that the nrf2 
gene transcription or its mRNA stability is not affected in the fat-1 mouse skin. 
An increased ω-3 fatty acid tissue level can augment the Nrf2-mediated 
induction of cytoprotective gene expression, which will neutralize ROS and 
reduce the oxidative damage to lipids and proteins, thereby ameliorating 






Fig. 2-1. fat-1 transgenic mice had higher amounts of ω-3 PUFAs in skin 
tissue as compared to that of WT mice. Both WT and fat-1 transgenic 
littermates born to the same mother were maintained on a diet (10% safflower 
oil) high in ω-6 and low in ω-3 fatty acids. (A) After the dietary regimen, the 
PUFAs profiles of mouse skin were analyzed using gas chromatography. 
Whereas high levels of ω-6 fatty acids characterized the WT samples, ω-3 fatty 
acids were nearly undetectable. (B) An abundance of docosahexaenoic acid, 
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DHA (22:6 n-3) was found in the fat-1 mouse skin. The DHA is marked with 
asterisks. (C) A significantly decreased level of ω-6 vs. ω-3 fatty acids was 
observed in the skin of fat-1 mice as compared to that of WT mice. Data are 







Fig. 2-2. UVB-induced inflammation and oxidative stress were attenuated 
in fat-1 mice compared with those in WT mice. (A) Skin thickness and 
apoptotic cells in WT and fat-1 mice were detected by H&E staining and the 
TUNEL assay, respectively at 24 h following 5.0 kJ/m2 UVB exposure. 
Formalin-fixed and paraffin-embedded tissues from the UVB-irradiated mice 
were also immunostained for MDA and 4-HNE. Magnifications ×100. (B) 
Isolated protein extracts were electrophoresed, transferred to a PVDF 
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membrane, and the membranes were probed using antibodies for 4-HNE. 
Quantification of 4-HNE was normalized to that of actin followed by statistical 
analysis of relative band density. Result is expressed as means ± SE. ***p 





Fig. 2-3. UVB-induced expression of COX-2 and iNOS was decreased in 
the skin of fat-1 mice as compared to that in the WT mouse skin. Animal 
treatment and other experimental details are same as described in the legend to 
Fig. 2-2. (A) Total RNA was isolated from the skin tissues using TRIzol® 
reagent according to the manufacturer’s protocol. RT-PCR analysis was 
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performed to detect the mRNA expression of cox-2. (B) Collected skin tissues 
were placed on ice and fat was removed to get an epidermal layer. Whole tissue 
extracts were analyzed for the protein expression of COX-2 and iNOS by 
immunoblotting. Quantification of COX-2 and iNOS was normalized to those 
of actin followed by statistical analysis of relative band density. Data are 
expressed as means ± SE. *p <0.05 and ***p <0.001 versus UVB-irradiated 
WT mice. (C) The respective sections were immunostained for COX-2 and 
counterstained with hematoxylin. Positive COX-2 staining yielded a brown-
colored product. Magnifications ×100. 
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Fig. 2-4. UVB-induced phosphorylation of STAT3 and Akt was diminished 
in the fat-1 mouse skin compared with that in the WT mouse skin. Animal 
treatment and other experimental conditions are same as described in the Fig. 
2-2 legend section. (A) Whole lysates and nuclear extracts from the different 
groups were separated by electrophoresis on SDS-PAGE and immunoblotted to 
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detect total and phosphorylated forms of STAT3 (Tyr705) and Akt (Ser473). 
Quantification of P-STAT3 and P-Akt was normalized to those of STAT3 and 
Akt, respectively. Results are expressed as means ± SE. *p <0.05 versus UVB-
irradiated WT mice. (B) The sections of skin tissues were subjected to 






Fig. 2-5. The Nrf2-mediated induction of cytoprotective gene expression 
was elevated in the skin of fat-1 mice. Both WT and fat-1 mice had access to 
AIN-93 diet supplemented with 10% safflower oil (rich in ω-6 fatty acids) ad 
libitum for 5 weeks. The The dorsal hair of mice was trimmed 2 days before 
sacrifice. (A) Total RNA was isolated from the skin tissues and the mRNA 
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expression of ho-1, nqo1 and nrf2 was examined by RT-PCR analysis. 
Quantification of ho-1 and nqo1 was normalized to those of actin, followed by 
statistical analysis of relative band density. (B) The epidermal lysates were 
subjected to Western blot analysis to detect the protein expression of HO-1, 
NQO1 and Nrf2. Data are expressed as means ± SE. *p <0.05 and **p <0.01 
versus WT mice. (C) Paraffin-embedded skin tissue blocks were analyzed by 
immunohistochemistry and the levels of Nrf2 were compared between WT and 














The ω-6 PUFAs, especially arachidonic acid (AA), is a precursor of 
prostaglandins, leukotrienes and related compounds, which enhance 
inflammation (Jia et al. 2008). The western diet is abundant in ω-6 PUFAs, 
mainly from vegetable oils. In contrast, ω-3 PUFAs have anti-inflammatory and 
anti-oxidative properties of ω-3 PUFAs. The consumption of fish, rich in ω-3 
PUFAs, is recommended for its health benefits to protect against heart disease, 
diabetes and potentially cancer (Connor 2000). Consuming increased amounts 
of long chain ω-3 PUFAs results in a partial replacement of the AA in cell 
membranes by eicosapentanoic acid and DHA (Kang 2007). This leads to a 
decreased production of AA-derived pro-inflammatory mediators. Studies by 
Kang et al. (2004) suggested a new strategy for producing food that is enriched 
in ω-3 fatty acids from livestock carrying fat-1, an ω-3 fatty acid desaturase 
gene. Production of ω-3 fatty acids by the animals themselves would be a cost-
effective and sustainable way of meeting the increasing demand for ω-3 PUFAs 
and the ideal ω-6/ω-3 PUFA ratio. Thus, we utilized the fat-1 transgenic mice 
to investigate the effect of ω-3 PUFAs and ω-6/ω-3 PUFA ratio on 
inflammatory and oxidative skin damages without providing exogenous ω-3 
PUFAs in the their diet. There was a remarkable difference in the ω-6/ω-3 PUFA 
ratio between WT and fat-1 mouse skin. When both WT and fat-1 mice were 
maintained on the identical diet high in ω-6 but low in ω-3 fatty acids, the WT 
mice exhibited substantially high contents of ω-6 PUFAs but much lesser 
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amounts of ω-3 PUFAs, whereas the fat-1 mice capable of spontaneously 
generating ω-3 fatty acids had a lower ω-6/ω-3 PUFA ratio in their skin. Notably, 
the level of DHA, derived from the α-linolenic acid, was markedly higher, 
whereas the level of AA, derived from the ω-6 PUFA linoleic acid, was 
significantly lower in the skin from fat-1 mice. Thus, this allowed us to produce 
two different fatty acid profiles in the animals by using just a single diet and 
therefore eliminated the need of two different diets for a comparative study. 
The major cause of dermatologic disorders is acute or chronic exposure to 
UVB radiation. Since UVB radiation induces oxidative modification of cellular 
macromolecules through increased generation of ROS (Tyrrell 1995, Oberley 
et al. 2004, Petersen & Doorn 2004), we initially examined the effect of 
endogenously produced ω-3 PUFAs on the levels of proteins modified by MDA 
and 4-HNE. The UVB-induced peroxyl and hydroxyl radicals were rapidly 
scavenged, thereby reducing the accumulation of lipid peroxidation products in 
the fat-1 mouse skin. UVB-induced ROS generation triggers amplification of 
cellular survival signaling and contributes to cell proliferation (Afaq et al. 
2005). Since the endogenous ω-3 fatty acids were effective in preventing UVB-
induced epidermal thickness, hyperplasia and lipid peroxidation, it would be 
worthwhile to examine the anti-tumor promoting effect of fat-1 gene on 
experimentally induced photocarcinogenesis. 
The pathologic basis of UVB-induced tumor development is partially 
attributed to the local tissue inflammation. The aberrant induction of pro-
inflammatory enzymes has been implicated in inflammation-associated 
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carcinogenesis (Kundu & Surh 2012). The demonstration of COX-2 
downregulation in UVB-exposed fat-1 mouse skin in vivo is in good agreement 
with a previous study demonstrating the inhibition of UVB-induced expression 
of COX-2 and NAD(P)H oxidase-4, an enzyme involved in the generation of 
ROS, in mouse skin topically treated with DHA (Rahman et al. 2011). 
Oxidative stress occurs when the balance between ROS and antioxidant 
enzymes favors toward the former. That means the more production of 
antioxidant enzymes, the less generation of oxidative stress, thereby preventing 
chronic inflammatory tissue damage and neoplastic transformation of cells. For 
instance, the induction of HO-1 protected mice against experimental colitis 
(Paul et al. 2005) and chemically induced skin papillomagenesis (Paul et al. 
2005). Topical application of hemin, a HO-1 inducer, abrogated 12-O-
tetradecanoylphorbol-13-acetate-induced COX-2 expression and nuclear factor 
kappa B activation in mouse skin (Park et al. 2008). NQO1-null mice are more 
susceptible to benzo[α]pyrene (Long et al. 2000)- or 7,12-
dimethylbenz[a]anthracene (Long et al. 2001)-induced skin carcinogenesis. 
The beneficial effect of ω-3 PUFAs in health and diseases is due mainly to its 
powerful anti-inflammatory resistance against oxidative stress and ability to 
maintain a proper cellular redox status (Romieu et al. 2008). Others have shown 
that ω-3 PUFAs enhance the antioxidant defense system of animals and humans 
by increasing the production of antioxidant enzymes (Bhattacharya et al. 2005, 
Bhattacharya et al. 2007, Ramaprasad et al. 2005). In a previous study, higher 
levels of catalase and superoxide dismutase were found in muscle and liver of 
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fat-1 mice (Rahman et al. 2009). These data suggested that an enhanced ω-3 
PUFA tissue level potentially enhanced the antioxidant defense system, thereby 
helping reduce pathological conditions. The study presented here was also 
designed to examine the effect of an increased ω-3 PUFA status on the anti-
oxidative property of fat-1 mouse skin. Significant augmentation of antioxidant 
enzymes production, along with enhanced expression of Nrf2, was observed in 
the skin tissue of fat-1 mice. 
In conclusion, the present study demonstrates that the inflammation of mouse 
skin irradiated by UVB is significantly less severe in fat-1 transgenic mice than 
that in WT littermates. The protection from UVB-induced skin inflammation in 
fat-1 mice is correlated with the formation of anti-inflammatory as well as anti-
oxidative ω-3 PUFAs including DHA, down-regulation of pro-inflammatory 
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Ultraviolet B (UVB) radiation is the most prevalent environmental carcinogen 
that increases the risk of skin cancer. Persistent inflammation caused by 
oxidative tissue damage is a key pathologic event in UVB-induced skin 
photocarcinogenesis. Omega-6 (ω-6) and omega-3 (ω-3) polyunsaturated fatty 
acids (PUFAs) exert differential effects on the inflammatory and carcinogenesis 
processes. While ω-6 PUFAs promote inflammation and tumor development, 
ω-3 PUFAs possess anti-inflammatory and chemopreventive properties. Here, 
we investigated the effects of endogenously produced ω-3 PUFAs on UVB-
induced skin inflammation and photocarcinogenesis using fat-1 transgenic mice 
harboring ω-3 desaturase gene capable of converting ω-6 to ω-3 PUFAs. To 
avoid the inconvenience of removing hairs for inducing photocarcinogenesis 
by repeated long-term UVB irradiation, we generated hairless fat-1+/− and fat-
1−/− mice by cross-breeding male fat-1+/− transgenic mice with female SKH-1 
hairless mice. The ω-3/ω-6 PUFA ratio was significantly higher in the dorsal 
skin of hairless fat-1+/− mice than that in the fat-1−/− mice. Upon single exposure 
to UVB (180 mJ/cm2) irradiation, hairless fat-1+/− transgenic mice exhibited a 
significantly lower degree of epidermal hyperplasia and oxidative skin damage 
as compared to those observed in the skin of fat-1−/− mice. After repeated UVB 
irradiation thrice a week for 23 weeks, the incidence and the multiplicity of 
papillomas were also markedly reduced in the hairless fat-1+/− mice. The 
protection of fat-1+/− mice from the pathogenesis of inflammation and 
subsequent development of skin cancer was associated with decreased 
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phosphorylation of signal transducer and activator of transcription 3 (STAT3). 
Moreover, fat-1+/− mice expressed heme oxygenase-1 and NAD(P)H:quinone 
oxidoreductase 1, and their mRNA transcripts to a greater extent than did fat-
1−/− control mice, which were attributable to the elevated activation of nuclear 
factor erythroid-related factor 2 (Nrf2). Embryo fibroblasts from fat-1 mice 
were much less responsive to UVB than those from wild type animals, in terms 
of inducing pro-inflammatory enzyme expression and intracellular generation 
of reactive oxygen species. While the protein expression of Nrf2 was enhanced, 
the steady-state level of the Nrf2 mRNA transcript was barely changed in the 
fat-1 embryo fibroblasts. Furthermore, transient overexpression of fat-1 gene 
and incubation with docosahexaenoic acid in mouse epidermal JB6 cells 
resulted in the inhibition of Nrf2 ubiquitination, leading to stabilization of Nrf2 
protein. Taken together, our results indicate that functional fat-1 potentiates 
cellular defense against UVB-induced skin inflammation and 
photocarcinogenesis through elevated activation of Nrf2 and upregulation of 
cytoprotective gene expression. 
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Ultraviolet B (UVB) radiation is known to cause initiation as well as promote 
the clonal expansion of initiated cells to produce skin tumors. Exposure of skin 
to excessive UVB induces the production of reactive oxygen species (ROS) 
which results in massive infiltration of inflammatory cells, especially, 
neutrophils at the site of tissue injury (Wagener et al. 2013). ROS play 
important roles in the modulation of intercellular transduction pathways 
involved in each stage of carcinogenesis, i.e., initiation, promotion, and 
progression (Wittgen & van Kempen 2007). Thus, the blockade of abnormally 
activated inflammatory signaling through fortification of cellular anti-oxidative 
defense capacity can protect against UVB-induced skin carcinogenesis. 
One of the key enzymes mediating inflammatory signal transduction is 
cyclooxygenase-2 (COX-2) that catalyzes the rate-limiting step in the 
biosynthesis of prostaglandins. Studies on the molecular mechanisms 
underlying UVB-induced COX-2 overexpression in cultured cells as well as in 
mouse skin have identified distinct upstream regulators of inflammatory signal 
transduction, such as nuclear factor kappa B (NF-κB) and signal transducer and 
activator of transcription 3 (STAT3) (Smith et al. 2000, Lukiw et al. 1998, Lo 
et al. 2010, Xiong et al. 2014, Carpenter & Lo 2014, Koon et al. 2006, Gong et 
al. 2014). 
A battery of antioxidant enzymes play a central role in maintaining the 
cellular redox balance. Examples are hemeoxygenase-1 (HO-1) and 
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NAD(P)H:quinone oxidoreductase 1 (NQO1) that have been reported to protect 
skin from oxidative and inflammatory tissue injury and carcinogenesis. The 
proximal promoter regions of genes encoding HO-1 and NQO1 harbor a 
consensus sequence known as antioxidant response element (ARE), which is a 
preferred binding site of a redox-sensitive transcription factor, nuclear factor 
erythroid-related factor 2 (Nrf2) (Surh et al. 2008). 
Multiple lines of evidence from laboratory and clinical studies suggest that 
some naturally occurring substances that can inhibit the oxidative and 
inflammatory tissue damage act as potential cancer chemopreventive agents 
(Surh 2003). Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) present in fish 
oil and some plant-based diets have been reported to retain marked anti-
inflammatory and anti-oxidative properties, which contribute to their 
chemopreventive potential (Jho et al. 2004, Rahman et al. 2011). The ω-6/ω-3 
PUFA ratio has been considered essential for determining the risk for some 
human malignancies (Simonsen et al. 1998, Gago-Dominguez et al. 2003, 
Maillard et al. 2002, Xia et al. 2005). Kang et al. developed genetically 
engineered mice of C57BL6 background carrying a fat-1 gene which encodes 
an ω-3 fatty acid desaturase derived from Caenorhabditis elegans (Chung et al. 
2009, Kang et al. 2004). The transgenic mice are capable of converting ω-3 
PUFAs from ω-6 PUFAs, thereby maintaining a significantly elevated ω-3/ω-6 
PUFA ratio in their tissues and organs. In the present study, hairless fat-1+/− mice 
were generated by cross-breeding of male fat-1+/− transgenic mice with female 
SKH-1 hairless mice. By utilizing these hairless fat-1+/− transgenic mice 
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maintained on ω-6 PUFA containing diet, we investigated the effect of 
endogenously formed ω-3 PUFAs on the development of UVB-induced tumors 

















3. Material and Methods 
Development of an in vivo hairless fat-1+/− model 
Male transgenic fat-1+/− mice (Kang et al. 2004) were backcrossed (at least five 
times) to female mice with Skh:hr-1 hairless background (Charles River 
Laboratories, Wilmington, MA). Animals were kept in standard cages under 
specific pathogen-free conditions and were fed with a special diet (10% 
safflower oil), high in ω-6 and low in ω-3 PUFAs. All studies were approved 
by the Institutional Animal Care and Use Committee of Seoul National 
University. The offsprings were examined for the hairless phenotypes and 
genotyped for fat-1+/− heterozygosity using the Tissue-DirectTM PCR Kit 
(Lamda Biotech, Inc. St. Louis, MO). The genotyping primers of fat-1 were as 
follows: fat-1, 5’-CTG CAC CAC GCC TTC ACC AAC C-3’ (forward) and 5’-
ACA CAG CAG CAG ATT CCA GAG ATT-3’ (reverse). 
 
Preparation and maintenance of mouse embryonic fibroblasts (MEFs) 
fat-1 transgenic mice and wild-type (WT) C57BL/6 mice (Charles River 
Laboratories, Wilmington, MA) were maintained and housed in a climate-
controlled quarters (24 ± 1°C at 50% humidity) with a 12-h light/12-h dark 
cycle. They were given ad libitum access to 10% safflower oil diets and water. 
Male fat-1 and female WT mice were paired and the pregnancies were 
monitored. Embryos were obtained at the day 13.5 after paring and used to 
prepare fibroblasts after removing head, heart and legs. The tails of the embryos 
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were used to confirm the fat-1 genotype by PCR, and the embryo bodies were 
minced into small pieces and cultured in high glucose Dulbecco’s modified 
Eagle’s medium (DMEM; Gibco BRL, Grand Island, NY) supplemented with 
10% fetal bovine serum (FBS; Gibco BRL, Grand Island, NY) and kept at 37 °C 
with 5% CO2. 
 
Analysis of fatty acid composition 
Fatty acid profiles were determined by using gas chromatography as described 
previously (Kang & Wang 2005). Briefly, samples were grounded to powder 
under liquid nitrogen. They were subjected to extraction of total lipids and fatty 
acid methylation by heating at 100°C for 1 h with 14% boron trifluoride-
methanol reagent. Fatty acid methyl esters were analyzed by gas 
chromatography using a fully automated Agilent 7890A system (Agilent, Santa 
Clara, CA) equipped with a flame-ionization detector. Peaks of resolved fatty 
acids were identified by comparison with the fatty acid methyl ester reference 
standards (Sigma Aldrich, St. Louis, MO), and area percentage for all resolved 
peaks was measured by using the ChemStation software (Agilent Technologies, 
Palo Alto, CA). 
 
JB6 Cl41 cell culture 
The mouse epidermal cell line, JB6 Cl41, was obtained from the American Type 
Culture Collection (Manassas, VA), and its characterization was done by 
monitoring cell morphology, karyotyping, and the cytochrome c oxidase I assay. 
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The cells were maintained in minimum essential medium (MEM) containing 5% 
FBS, 25 μg/mL gentamicin, 0.01% sodium pyruvate and 1.5 mg/mL sodium 
bicarbonate in an atmosphere of 95% air and 5% CO2 at 37°C. MEM and 
gentamicin were purchased from Gibco BRL (Grand Island, NY). 
 
Source and protocols of UVB irradiation 
The UVB radiation source was a 5×8 Watt tube, which emits an energy 
spectrum with high fluency in the UVB region (with a peak at 312 nm). A 
Biolink BLX-312 UV crosslinker (Vilbert Lourmat, Marne-la-Valle´ e, France) 
was used to irradiate mouse skin (180 mJ/cm2 dose of UVB) and MEFs (20 
mJ/cm2 dose of UVB). The irradiated animals were allowed to move freely and 
with no more than five mice per cage. Dorsal skin samples were obtained for 
epidermal sheets 2 h later. In a skin papillomagenesis model, female hairless 
mice were irradiated with UVB (180 mJ/cm2) three times a week for 23 weeks. 
The irradiated mice were sacrificed, and their skin and tumors were collected 
for subsequent studies. 
 
Histological and immunohistochemical analyses of paraffin-embedded skin 
sections 
Sections of harvested mouse skin were washed with phosphate-buffered saline 
(PBS) and fixed with 10% buffered formalin and embedded in paraffin. Each 
section (4 μm) was stained with hematoxylin and eosin (H&E). The H&E 
stained sections were examined under light microscope to detect the presence 
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of lesions. Immunohistochemistry (IHC) of formalin-fixed and paraffin-
embedded tissue specimens were performed to detect the expression of P-
STAT3, COX-2, 4-hydroxy-2-nonenal (4-HNE)-modified protein and Nrf2. 
The sections were cut on silanized glass slides, deparaffinized three times with 
xylene and rehydrated through graded alcohol bath. The deparaffinized sections 
were heated by using microwave and boiled twice for 6 min in 10 mM citrate 
buffer (pH 6.0) for antigen retrieval. To diminish nonspecific staining, each 
section was treated with 3% hydrogen peroxide and 4% peptone casein 
blocking solution for 15 min. For the detection of respective protein expression, 
slides were incubated with P-STAT3 (Cell Signaling Technology, Beverly, MA), 
COX-2 (Cayman Chemical Co., Ann Arbor, MI), proteins modified with 4-
HNE (JaICA, Nikken SEIL Co. Ltd., Shizuoka, Japan) and Nrf2 (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) antibodies at room temperature for 40 
min in Tris-buffered saline containing 0.05% Tween 20, and then developed 
using horseradish peroxidase-conjugated secondary antibodies (rabbit or mouse) 
(Dako, Glostrup, Denmark). The peroxidase binding sites were detected by 
staining with 3,3’-diaminobenzidine tetrahydrochloride. Finally, 
counterstaining was performed using Mayer’s hematoxylin. 
 
Tissue lysis and protein extraction 
For the preparation of mouse epidermal protein extract, fat and dermis were 
removed from the harvested skin samples kept on ice, and the fat-free epidermis 
was immediately placed in liquid nitrogen and pulverized in mortar. The 
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pulverized skin was homogenized on ice for 20 s with a polytron tissue 
homogenizer and lysed in 1 mL ice-cold lysis buffer [150 mM NaCl, 0.5% 
Triton-X 100, 50 mM Tris–HCl (pH 7.4), 20 mM ethylene glycol tetra-acetic 
acid, 1 mM dithiothreitol (DTT), 1 mM Na3VO4 and protease inhibitors, 1 mM 
phenylmethyl sulfonylfluoride (PMSF) and ethylenediaminetetraacetic acid 
(EDTA)-free cocktail tablet] followed by a periodical vortex for 30 min at 0°C. 
In other studies, MEFs and JB6 C141 cells were incubated with linoleic acid 
(LA), arachidonic acid (AA), docosahexaenoic acid (DHA; Cayman Chemical 
Co., Ann Arbor, MI), dimethyl sulfoxide (DMSO; Amresco, Solon, OH), 
cycloheximide (Sigma-Aldrich, St. Louis, MO) or MG132 (Enzo Life Sciences, 
Inc., Farmingdale, NY) for indicated durations. The treated cells were harvested, 
washed with PBS and suspended in the lysis buffer as mentioned above for 1 h 
on ice. The lysates were centrifuged at 14,800 g for 15 min at 4 ºC. The aliquots 
collected from the supernatant containing protein were stored at -70°C until use. 
 
Preparation of cytosolic and nuclear extracts 
Scraped dorsal skin of mice was homogenized in 800 μL of hypotonic buffer A 
[10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 7.8), 
1.5 mM MgCl2, 10 mM KCl, 1 mM DTT, 0.1 mM EDTA and 0.1 mM PMSF]. 
To the homogenates was added 80 μL of 10% Nonidet P-40 (NP-40) solution, 
and the mixture was then centrifuged for 2 min at 14,800 g. The supernatant 
was collected as cytosolic fraction. The precipitated nuclei were washed once 
with 500 L of buffer A plus 50 l of 10% NP-40, centrifuged, resuspended in 
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200 L of buffer C [50 mM HEPES (pH 7.8), 50 mM KCl, 300 mM NaCl, 0.1 
mM EDTA, 1 mM DTT, 0.1 mM PMSF and 20% glycerol] and centrifuged for 
5 min at 14,800 g. The supernatant containing nuclear proteins was collected 
and stored at -70C. 
 
Western blot analysis 
For Western blot analysis, the protein concentration of whole cell lysates and 
cytosolic extract was measured by using the bichinconinic acid protein assay 
kit (Pierce, Rockford, IL), while that of nuclear extract was quantified by using 
the Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA). Cell 
lysates (30 μg protein) were boiled in sodium dodecyl sulfate (SDS) sample 
loading buffer for 5 min before electrophoresis on 8-15% SDS-polyacrylamide 
gel (SDS-PAGE). After transfer to a polyvinylidene difluoride (PVDF) 
membrane (Gelman Laboratory, Ann Arbor, MI), the blots were blocked with 
5% fat-free dry milk in tris-buffered saline containing 0.1% tween 20 (TBST) 
for 1 h at room temperature. The membranes were incubated for 12-24 h at 4°C 
with dilutions of primary antibodies for P-STAT3, STAT3, HA-tag (Cell 
Signaling Technology, Beverly, MA), lamin B, ubiquitin (Invitrogen, Carlsbad, 
CA), COX-2 (Cayman Chemical Co., Ann Arbor, MI), actin (Sigma Aldrich, St. 
Louis, MO), proteins modified with 4-HNE (JaICA, Nikken SEIL Co. Ltd., 
Shizuoka, Japan), HO-1 (Stressgen Biotechnologies Co., San Diego, CA), 
NQO1 (Abcam Inc., Cambridge, MA), Nrf2 and α-tubulin (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA). Blots were washed three times with 
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TBST at 7 min intervals followed by incubation with 1:3000 dilution of 
respective horseradish peroxidase conjugated secondary antibodies (rabbit, 
mouse or goat) in 3% fat-free dry milk-TBST for 2 h at room temperature. The 
blots were rinsed again three times with TBST. The immunoblots were 
visualized with an enhanced chemiluminescent (ECL) detection kit (Amersham 
Pharmacia Biotech, Buckinghamshire, UK) and LAS-4000 image reader 
(Fujifilm, Tokyo, Japan) according to the manufacturer’s instructions. 
 
Reverse transcription-polymerase chain reaction analysis (RT-PCR) 
Total RNA was isolated from mouse skin tissues using TRIzol® reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. To 
generate the cDNA from RNA, 1 µg of total RNA was reverse transcribed with 
murine leukemia virus reverse transcriptase (Promega, Madison, WI) for 50 
min at 42°C and again for 15 min at 72°C. About 1 μL of cDNA was amplified 
with a PCR mixture (HS Prime Taq 2X Premix, Daejeon, South Korea) in 
sequential reactions. The primers used for each RT-PCR reactions are as 
follows : cox-2, 5’-CTG GTG CCT GGT CTG ATG ATG-3’ and 5’-GGC AAT 
GCG GTT CTG ATA CTG-3’; actin, 5’-AGA GCA TAG CCC TCG TAG AT-
3’ and 5’-CCC AGA GCA AGA GAG GTA TC-3’; ho-1, 5’-TAC ACA TCC 
AAG CCG AGA AT-3’ and 5’-GTT CCT CTG TCA GCA TCA CC-3’; nqo1, 
5’-TCG GAG AAC TTT CAG TAC CC-3’ and 5’-TGC AGA GAG TAC ATG 
GAG CC-3’; nrf2, 5’-CCT CTG TCA CCA AGC TCA AGG-3’ and 5’-TTC 
TGG GCG GCG ACT TTA TT-3’ (forward and reverse, respectively). 
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Amplification products were analyzed by 2-3% agarose gel electrophoresis, 
followed by staining with SYBR Green (Invitrogen, Carlsbad, CA) and 
photographed using fluorescence in LAS-4000 (Fujifilm, Tokyo, Japan). 
 
Measurement of intracellular ROS accumulation 
The accumulation of ROS in UVB‐irradiated MEFs was monitored using the 
fluorescence-generating probe 2’,7’-dichlorofluorescein diacetate (DCF-DA; 
Invitrogen, Carlsbad, CA). Treated cells were rinsed twice with Hanks’ 
balanced salt solution (HBSS, Cellgro, Herndon, VA) and loaded with 10 μM 
DCF-DA for 30 min in a 5% CO2 incubator to assess ROS-mediated oxidation 
of DCF-DA to the fluorescent compound DCF. Cells were washed twice with 
HBSS, suspended in the complete media and examined under a 
micromanipulator system (Leica Microsystems, Heidelberg, Germany). 
 
Transient transfection with Nrf2 siRNA 
Nrf2 siRNA and StealthTM universal RNAi negative control duplexes were from 
Invitrogen (Carlsbad, CA). The target sequence for Nrf2 siRNA is as follow: 
forward 5’-AAG AGU AUG AGC UGG AAA AAC UU-3’and reverse 5’-GUU 
UUU CCA GCU CAU ACU CUU UU-3’. MEFs were seeded at a density of 4 
x 104 cells/mL in 60-mm petridishes and grown to 60-70% confluence. Nrf2 
siRNA (20 μM) was transfected into MEFs with Lipofectamine® RNAi-MAX 
reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. 
After 48-h transfection, cells were treated with LA (50 μM) and AA (50 μM) 
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for additional 24 h, and cell lysates were prepared as described earlier. 
 
Construction of plasmid pCMV-HA-N-fat-1 
The murine full-length fat-1 was amplified by RT-PCR from the total RNA 
obtained from the tails of fat-1 mice with primers 5’-CAT GGA GGC CCG 
AAT TCG GAT GGT CGC TCA TTC CTC A-3’ (forward) and 5’- ATC CCC 
GCG GCC GCG GTA CCT TAC TTG GCC TTT GCC TT-3’ (reverse) and 
subcloned into HA-tagged-pCMV expression vector (Clontech Laboratories, 
Inc., Mountain View, CA) as EcoRI/KpnI fragment. One day before transfection, 
JB6 C141 cells were seeded at a density of 3 x 104 cells/mL in a 60-mm dishes 
and grown to 40–50% confluence growth media without antibiotic at 37℃ in a 
humidified atmosphere of 5% CO2/95% air. The fat-1 overexpresion vector (50 
nM) was transfected into JB6 Cl41 cells with Lipofectamine® 2000 reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. After 
24-h transfection, cells were treated with LA (25 μM) and AA (25 μM) for 
additional 48 h, and cell lysates were prepared as described earlier. 
 
Immunoprecipitation 
JB6 cells were treated with DHA and AA for indicated time and lysed in 250 
mM sucrose, 50 mM Tris-HCl (pH 8.0), 25 mM KCl, 5 mM MgCl2, 1 mM 
EDTA, 2 μM NaF, 2 μM sodium orthovanadate, 1 mM PMSF and 10 mM N-
ethylmaleimide. Total protein (500 μg) was subjected to immunoprecipitation 
by shaking with Nrf2 primary antibody at 4℃ for 24 h followed by the addition 
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of 40 μL of 25% protein G-agarose bead slurry (Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA) and additional shaking for 2 h at 4℃. After centrifugation at 
10,000 g for 1 min, immunoprecipitated beads were collected by discarding the 
supernatant and washed with cell lysis buffer. After final wash, 
immunoprecipitate was resuspended in 50 μL of 2X SDS electrophoresis 
sample buffer and boiled for 5 min. Forty five-μL of supernatant from each 
sample was loaded on SDS-PAGE. The ubiquitinated Nrf2 was visualized by 
antibody against ubiquitin (Life Technologies, Carlsbad, CA). 
 
Statistical analysis 
Except for the data on the body weight change and multiplicity expressed as 
the mean ± standard deviation (SD), all other values were expressed as the mean 
± standard error (SE) of at least three independent experiments. Statistical 
significance was determined by Student’s t-test and a p-value of less than 0.05 
was considered to be statistically significant. 
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4. Results 
Generation of hairless fat-1+/− mice and fatty acid profiles of their skin tissues 
Hairless animals are known to be more susceptible to the induction of squamous 
cell carcinomas than their haired littermates (Kim et al. 2012). The fat-1 gene 
of C. elegans encodes an ω-3 fatty acid desaturase that converts ω-6 to ω-3 
PUFAs, but this gene is absent in mammals (Kang 2007). To determine whether 
an increased ω-3 PUFA tissue accumulation is protective against repeated 
UVB-induced skin inflammation and photocarcinogenesis, we generated 
hairless fat-1 mice by crossing fat-1+/− haired and SKH-1 hairless mice as 
shown in Fig. 3-1A. Thus, the ‘fat-1’ transgenic mice of the C57BL6 strain 
were subsequently backcrossed five times to SKH-1 hairless mice. The fat-
1+/−  animals were segregated for the hairless phenotype. The resulting mice had 
the predominant genetic background of Skh:hr-1 hairless (>96.875%). All the 
experiments were performed by comparing mice of the same genetic 
background with or without carrying the fat-1 transgene. The hairless mutation 
showed normal development of the hair coat in the first hair cycle. Starting at 
the 2 week of age, they lost their hair coat rapidly (Sundberg & King 2001). At 
weaning, they were completely hairless. Both hairless fat-1−/− and fat-
1+/− littermates born to the same mother were maintained on an identical diet 
containing ω-6 PUFAs, but deficient in ω-3 ones. Analysis of the total lipids 
extracted from skin tissues of hairless fat-1+/− mice showed a PUFA profile 
distinct from that of hairless fat-1−/− (Fig. 3-1B and Table 3-1). There were 
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significantly lower levels of ω-6 PUFAs and much higher proportions of ω-3 
PUFAs in the skin of hairless fat-1+/− mice compared to those fat-1−/− mouse 
skin. The ratios of the ω-6 (18:2n-6, 18:3n-6, 20:3n-6 and 20:4n-6) to the ω-3 
PUFAs (18:3n-3, 20:3n-3, 20:5n-3 and 22:6n-3) in skin tissues of hairless fat-
1−/− and fat-1+/− mice were 15.48:1 and 3.77:1, respectively. This indicates that 
the transgene is functionally active and transmittable. 
 
UVB-induced inflammation was ameliorated in fat-1+/− mouse skin 
First, we investigated whether an elevated ω-3 PUFA tissue level in hairless fat-
1+/− mice protects against UVB-induced inflammation. Hairless fat-1+/− mice 
developed less severe skin hyperplasia compared with their fat-1−/− littermates 
(Fig. 3-2A, upper panels). Persistently activated STAT3 plays an important role 
in photocarcinogenesis through upregulation of genes involved in tumor-
associated inflammation, anti-apoptosis and proliferation (Kim et al. 2009a). 
One of the essential events in activation of STAT3 signaling is phosphorylation 
at its tyrosine 705 residue (Tyr705). As shown in Fig. 3-2A (lower panels), 
hairless fat-1−/− mice irradiated with UVB exhibited markedly increased 
expression of P-STAT3 (Tyr705) which appeared as brown color staining. A 
significantly lower proportion of phosphorylated STAT3-positive cells was 
observed in fat-1+/− mouse skin irradiated with UVB. Lysates of both total and 
nuclear extracts of skin tissues were subjected to Western blot analysis of the 
phosphorylation of STAT3 at Tyr705. Whole tissue lysates and nuclear extracts 
from fat-1+/− mouse skin showed markedly decreased nuclear translocation of 
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P-STAT3 after UVB irradiation compared with fat-1−/− mouse skin (Fig. 3-2B). 
 
UVB-induced skin tumor development was suppressed in hairless fat-
1+/− mice compared with that in fat-1−/− mice 
After repeated UVB irradiation thrice a week for 23 weeks, representative 
photographs of mice from different groups were taken. Fig. 3-3A shows that 
the tumor burden in the hairless fat-1+/− mice was much lower than that in the 
hairless fat-1−/− mice. The smallest tumor in the hairless fat-1−/− mice was still 
bigger than the biggest one in the hairless fat-1+/− mice. We monitored the body 
weight of each mouse every week until termination of the experiment. The body 
weight change of UVB-exposed mice was decreased compared with the mice 
in the control group. However, hairless fat-1+/− mice exhibited body weight 
reduction caused by UVB to a lesser extent than the hairless fat-1−/− mice (Fig. 
3-3B, upper left panel). As shown in the upper right panel of Fig. 3-3B, there is 
a marked difference in the onset of tumor formation between hairless fat-1−/− 
and fat-1+/− mice. About the half of hairless fat-1−/− mice irradiated with UVB 
developed skin papillomas at the 14th week which reached 100% at the 18th 
week. However, the first appearance of skin papillomas in hairless fat-1+/− mice 
was observed at the 16th week, and the 100% tumor incidence was attained at 
the 23th week. The tumor multiplicity between the two experimental groups was 
also significantly different (Fig. 3-3B, lower left panel). In the hairless fat-
1+/− mice, the average number of tumors per mouse was 7 compared with 16.5 
in the hairless fat-1−/− littermates. Likewise, the cumulative number of 
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papillomas was markedly reduced in hairless fat-1+/− mice (Fig. 3-3B, lower 
right panel). Our data clearly demonstrate a pronounced inhibition of 
inflammation and papilloma formation in UVB-irradiated skin of the hairless 
fat-1+/− mice, which is attributable to an increased ω-3 to ω-6 PUFA ratio. 
 
UVB-induced expression of COX-2 and phosphorylation of STAT3 were 
diminished in the papillomas of hairless fat-1+/− mice compared with those in 
the fat-1−/− mice 
COX-2 is an inducible prostaglandin synthase responsible for producing a 
distinct set of prostaglandins and thromboxanes involved in inflammatory 
processes. Inappropriate upregulation of COX-2 induces malignant changes in 
epidermal keratinocytes (Rundhaug & Fischer 2010) and prolongs the survival 
of malignant or transformed cells with metastatic potential (Surh et al. 2001). 
STAT3 is a well known transcription factor involved in the regulation of COX-
2 (Koon et al. 2006). A significant decrease in expression of COX-2 at both 
transcriptional (Fig. 3-4A) and translational (Fig. 3-4B) levels was noted in the 
papillomas of the hairless fat-1+/− mice. Concomitant with downregulation of 
COX-2, the level of P-STAT3 (Tyr705) was also markedly reduced in fat-
1+/− mouse skin irradiated with UVB (Fig. 3-4B). The above findings were also 
verified by H&E staining and immunohistochemical analysis. The thickening 
of epidermal layer and inflammatory cell infiltration in UVB-irradiated fat-1−/− 
mouse skin were less severe in fat-1+/− skin (Fig. 3-4C, upper panels). Likewise, 
expression of COX-2 (Fig. 3-4C, middle panels) and P-STAT3 (Fig. 3-4C, 
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lower panels) in the skin of fat-1+/− mice was substantially reduced. 
 
UVB-induced oxidative skin damage was attenuated in fat-1+/− mice 
Multiple lines of evidence suggest that UVB-induced generation of ROS, such 
as superoxide anion, hydroxyl radical and hydrogen peroxide, is responsible for 
skin hyperplasia (Tyrrell 1995) as well as lipid peroxidation (Halliday 2005). 
4-HNE is a representative lipid peroxidation product (Oberley et al. 2004, 
Petersen & Doorn 2004). There was lesser 4-HNE-induced protein 
modification in the hairless fat-1+/− mouse skin as compared to fat-1−/− one upon 
acute UVB irradiation (Fig. 3-5A). Moreover, repeated exposure to UVB up to 
23 weeks increased the 4-HNE-modified protein expression, which was blunted 
in the skin of fat-1+/− mice (Fig. 3-5B). 
 
The Nrf2-mediated induction of cytoprotective gene expression was elevated 
in the skin of fat-1+/− mice 
Exposure to UVB is known to generate ROS which can cause oxidative stress. 
This may trigger an adaptive antioxidant response to protect cells from 
oxidative damage. To investigate whether the decreased number of papillomas 
formed by UVB irradiation is attributable to augmentation of cellular defense 
capacity that counteract excessive ROS accumulation, we analyzed the 
antioxidant gene expression in the skin of fat-1+/− mice. We found a robust 
enhancement in the expression of two representative cytoprotective enzymes 
HO-1 and NQO1, at both transcriptional and translational levels, in the fat-1+/− 
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(Fig. 3-6A and B). Nrf2 plays a critical role in transcriptional activation of 
genes encoding HO-1 and NQO1. Enhanced nuclear accumulation of Nrf2 was 
observed in the skin of fat-1+/− (Fig. 3-6B and C). Consistently, the 
stabilization of Nrf2 protein was observed in the hairless fat-1+/− mouse skin at 
the 23rd week, as measured by Western blot analysis (Fig. 3-6D). Compared 
with their respective age-matched skin of fat-1−/− mice, no significant change 
in the epidermal level of Nrf2 mRNA was found in the fat-1+/− mice (Fig. 3-6A) 
which is in a good agreement with a previous finding (Yang et al. 2013). These 
findings suggest that the epidermal nrf2 gene transcription is not affected by an 
increased ω-3 PUFA production in fat-1+/− and that its protein expression is 
likely to be regulated by post-transcriptional mechanisms. 
 
UVB-induced inflammation and oxidative stress were less severe in fat-1 
MEFs than those in WT MEFs 
It has been reported that changes in fatty acid composition occur in the early 
stage of embryo-genesis and last for the whole life in the fat-1 transgenic mice 
(Kang 2007). To further confirm the in vivo findings, MEF cells were isolated 
from both WT and fat-1 transgenic mice. A significantly lower level of the ω-
6/ω-3 fatty acid ratio was observed in fat-1 MEF cells as compared to WT MEF 
cells (Fig. 3-7A and Table 3-2). Reduced levels of ω-6 PUFAs, especially LA 
and AA, were found in the fat-1 MEF cells as compared to the WT MEF cells. 
However, the reduction of ω-6 PUFA levels in the fat-1 MEF cells was not as 
dramatic as increases in ω-3 PUFA. To elucidate the role of the fat-1 transgene 
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in UVB-induced inflammatory and oxidative insults, MEF cells were incubated 
with representative ω-6 PUFAs, LA and AA, followed by UVB irradiation. 
COX-2 expression was further enhanced in WT MEF cells with co-expression 
of an active form of STAT3 (P-STAT3). COX-2 expression and STAT3 
phosphorylation were attenuated in UVB-exposed fat-1 MEFs (Fig. 3-7B). 
Next, we examined the effect of fat-1 gene against intracellular ROS production 
in UVB-irradiated MEF cells. As illustrated in Fig. 3-7C, UVB-irradiated MEF 
cells showed an enormous increase in the ROS accumulation as compared to 
control cells. The ROS generation was further enhanced in the fat-1 deficient 
MEFs incubated with ω-6 PUFAs, LA and AA. However, the increased ω-6/ω-
3 fatty acid ratio blocked UVB-induced ROS overproduction in the fat-1 MEFs. 
The fat-1 MEF cells exhibited upregulation of the two representative 
antioxidant enzymes, HO-1 and NQO1, at both transcriptional and translational 
levels, to a greater extent than WT MEF cells upon treatment with LA plus AA 
(Fig. 3-7D). Further, siRNA knock down of nrf2 gene abrogated the expression 
of HO-1 and NQO1 in fat-1+/− MEF cells (Fig. 3-7E). This finding indicates 
that Nrf2 is essential for the induction of cytoprotective gene expression in fat-
1 MEF cells. 
 
DHA increased the stability of Nrf2 protein in mouse epidermal JB6 cells 
In another experiment, mouse epidermal JB6 cells were transfected with either 
pCMV-HA-control vector or pCMV-HA-fat-1 vector. Overexpression of fat-1 
gene increased the Nrf2-mediated expression of cytoprotective enzymes (Fig. 
６８ 
3-8A). In contrast to the altered Nrf2 protein expression, JB6 cells transiently, 
transfected with pCMV-HA-fat-1 vector exhibited no significant alteration in 
the steady state level of its mRNA transcript (Fig. 3-8A). To determine whether 
DHA stabilizes Nrf2 protein without inducing de novo synthesis, we monitored 
the degradation of basal and DHA-induced Nrf2 protein in JB6 cells after 
inhibition of protein synthesis by cycloheximide. As illustrated in Fig. 3-8B, 
Nrf2 protein in untreated control cells degraded rapidly after addition of 
cycloheximide, whereas Nrf2 in the DHA-treated JB6 cells underwent 
degradation more slowly. As shown in Fig. 3-8C, treatment of JB6 cells with 
the proteasome inhibitor, MG-132 significantly increased the level of Nrf2. 
Moreover, most proteins subjected to proteasomal degradation are marked by 
prior, covalent ligation of ubiquitin molecules to the ε-amino group of specific 
lysine residues. A ubiquitination assay revealed that the appearance of 
ubiquitinated Nrf2 was decreased with a concomitant increase in Nrf2 







Fig. 3-1. Generation of hairless fat-1+/− mice and the analysis of their skin 
PUFA composition. (A) fat-1+/− haired mice (a) were crossed with SKH-1 
hairless mice (b) to generate fat-1−/− and fat-1+/− progenies. Hairless fat-
1−/− and fat-1+/− mice during (c−g) and after (h) first hair cycle. After an initial 
hair cycle, the skin became eventually hairless, suitable for all studies to be 
７０ 
undertaken. (B) Both hairless fat-1−/− and fat-1+/− littermates born to the same 
mother were maintained on a diet (10% safflower oil) high in ω-6 and low in 
ω-3 fatty acids. After the dietary regimen, the PUFA profiles of mouse skin 
were analyzed by gas chromatography. Significantly elevated levels of ω-3 vs. 
ω-6 fatty acids were observed in skin tissues of hairless fat-1+/− mice as 
compared to those of hairless fat-1−/− mice. Data are expressed as means ± SE. 


















Table 3-1. PUFA composition in the skin of hairless fat-1 transgenic and 
wild-type mice. 
  fat-1−/− fat-1+/− 
Linoleic acid C18:2 31.81 ± 0.62  27.06 ± 0.86a 
γ-Linolenic acid C18:3 0.46 ± 0.06 0.22 ± 0.01a 
Dihomo-γ-linolenic acid  C20:3 1.03 ± 0.04 0.54 ± 0.06b 
Arachidonic acid C20:4 0.37 ± 0.02 0.04 ± 0.01c 
ω-6 PUFAs (%)  33.66 ± 0.60 27.86 ± 0.89b 
α-Linolenic acid  C18:3 0.90 ± 0.04  2.46 ± 0.13c 
Eicosatrienoic acid C20:3 0.56 ± 0.06  1.03 ± 0.01b 
Eicosapentaenoic acid C20:5 0.35 ± 0.04  1.29 ± 0.02c 
Docosahexaenoic acid  C22:6 0.36 ± 0.01  2.63 ± 0.11c 
ω-3 PUFAs (%)  2.18 ± 0.03  7.41 ± 0.24c 
ω-6/ω-3 PUFAs   15.48 ± 0.48  3.77 ± 0.22c 
ω-3/ω-6 PUFAs   0.06 ± 0.004  0.27 ± 0.02c 
Data are expressed as means ± SE (n = 3). 
ap <0.05, bp <0.01 and cp <0.001 versus hairless fat-1−/− mice. 
７２ 
 
Fig. 3-2. UVB-induced inflammation was ameliorated in fat-1+/− mouse 
skin. Newly developed female hairless mice (n = 3 per treatment group) were 
topically treated on their backs with UVB radiation (180 mJ/cm2). (A) Skin 
thickness in hairless fat-1−/− and fat-1+/− mice was visualized by H&E staining 
at 2 h following UVB exposure. Formalin-fixed and paraffin-embedded tissues 
from UVB-irradiated mice were also immunostained for phospho-STAT3 
(Tyr705), and counterstained with hematoxylin. Magnifications, ×100. (B) 
Whole lysates and nuclear extracts from different groups were subjected to 
SDS-PAGE and immunoblotted to detect total and phosphorylated forms of 
STAT3 (Tyr705). Quantification of P-STAT3 was normalized to that of STAT3 
and lamin B, followed by statistical analysis of relative band density. Data are 




Fig. 3-3. UVB-induced skin tumor development was suppressed in hairless 
fat-1+/− mice compared with that in fat-1−/− mice. The female hairless fat-
1−/− or fat-1+/− mice (n = 10 per group) were irradiated with UVB (180 mJ/cm2) 
three times a week until termination of the experiment. (A) The photographic 
images represent papillomas formed at the 23rd week of UVB treatment. (B) 
７４ 
The body weight change was measured on a weekly basis. Starting four week 
following UVB treatment, tumors of at least 1 mm diameter were counted every 
week till the 23rd weeks. The results were expressed as the percentage of 
papilloma-bearing mice (incidence), the average number of papillomas per 
mouse (multiplicity) and the cumulative number of papillomas. Data are 
expressed as means ± SD. *p <0.05 and ***p <0.001 versus UVB-irradiated 




Fig. 3-4. UVB-induced expression of COX-2 and phosphorylation of 
STAT3 were diminished in the papillomas of hairless fat-1+/− mice 
compared with those in the fat-1−/− mice. Animal treatment and other 
experimental details are described in the legend to Fig. 3-3. (A) Total RNA was 
isolated from skin tissues, and mRNA expression of cox-2 was examined by 
RT-PCR analysis. Quantification of cox-2 was normalized to that of actin, 
７６ 
followed by statistical analysis of relative band density. (B) Whole surrounding 
tissue extracts (30 μg protein) were analyzed for the expression of COX-2 and 
P-STAT3 (Tyr705) by immunoblotting. Quantification of COX-2 and P-STAT3 
was normalized to that of actin, followed by statistical analysis of relative band 
density. Results are expressed as means ± SE. **p <0.01 and ***p <0.001 
versus UVB-irradiated hairless fat-1−/− mice. (C) H&E staining of papillomas 
showed hypertrophic squamous epithelium forming papillary fronds. The 
sections of skin tissues were also subjected to immunohistochemical analysis 
of COX-2 and P-STAT3 (Tyr705). Positive COX-2 and P-STAT3 (Tyr705) 






Fig. 3-5. UVB-induced oxidative skin damage was attenuated in fat-1+/− 
mice. (A) Animal treatment is same as described in the legend to Fig. 3-2. 
Isolated protein extracts were electrophoresed and transferred to a PVDF 
membrane, which was probed using antibody for 4-HNE. Quantification of 4-
HNE was normalized to that of actin followed by statistical analysis of relative 
band density. Results are expressed as means ± SE. ***p <0.001 versus UVB-
irradiated hairless fat-1−/− mice. Formalin-fixed and paraffin-embedded tissues 
from UVB-irradiated mice were immunostained for detecting the 4-HNE-
modified protein expression. Magnifications, ×100. (B) Experimental 
conditions are same as described in the legend to Fig. 3-3. Western blot analysis 
of 4-HNE-modified protein expression in the skin papillomas of hairless fat-
1−/− and fat-1+/− mice. Quantification of 4-HNE was normalized to that of actin 
７８ 
followed by statistical analysis of relative band density. ***p <0.001 versus 







Fig. 3-6. The Nrf2-mediated induction of cytoprotective gene expression 
was elevated in the skin tissues of hairless fat-1+/− mice. Hairless fat-1−/− and 
fat-1+/− mice (n = 3 per treatment group) were maintained on AIN-93 diet 
supplemented with 10% safflower oil (rich in ω-6 fatty acids) for 5 weeks. (A) 
RT-PCR analysis was conducted to measure the mRNA levels of ho-1, nqo1 
８０ 
and nrf2. Quantification of ho-1 and nqo1 was normalized to that of actin, 
followed by statistical analysis of relative band density. (B) Collected skin 
tissues were placed on ice and fat was removed to get an epidermal layer. The 
epidermal lysates and nuclear extracts were separated by electrophoresis on 
SDS-PAGE and immunoblotted to detect protein expression of HO-1, NQO1 
and Nrf2. Quantification of HO-1, NQO1 and Nrf2 immunoblot was 
normalized to that of actin and lamin B, followed by statistical analysis of 
relative band density. (C) Paraffin-embedded skin tissue blocks were analyzed 
by immunohistochemistry and the levels of Nrf2 (brown spots) were compared 
between hairless fat-1−/− and fat-1+/− mice. Magnifications, ×100. (D) After 23 
weeks of feeding the 10% safflower oil diet, whole tissue extracts (30 μg 
protein) were analyzed for the protein levels of Nrf2-regulated antioxidant 
genes by immunoblotting. Quantification of HO-1, NQO1, and Nrf2 
immunoblot was normalized to that of actin, followed by statistical analysis of 
relative band density. Data are expressed as means ± SE. *p <0.05, **p <0.01 







Fig. 3-7. UVB-induced inflammation and oxidative stresses were less severe 
in fat-1 MEFs than that in WT MEFs. At 4 weeks of age, male fat-1 
transgenic and female WT littermates fed with the 10% safflower oil and 
maintained throughout mating, pregnancy, and lactation on the same diet. 
Embryos were isolated from those mice and used to prepare fibroblasts. (A) 
８２ 
PUFA profiles of MEFs were attained by using gas chromatography. 
Significantly decreased levels of ω-6 vs. ω-3 fatty acids were observed in MEFs 
derived from fat-1 mice compared with those in WT MEFs. Results are 
expressed as means ± SE. ***p <0.001 versus WT MEFs. (B) MEF cells were 
incubated with LA and AA (50 M each) for 24 h before exposure to UVB 
radiation (20 mJ/cm2). After 1 h of UVB irradiation, cells were subjected to RT-
PCR for mRNA expression of cox-2, and Western blot analysis for the protein 
expression of COX-2 and a phosphorylated form of STAT3 (Tyr705). (C) MEF 
cells treated as described above were subjected to the DCF-DA assay. 
Enhancement of UVB-induced intracellular ROS generation was observed in 
absence of fat-1 gene. (D) MEF cells were incubated with or without LA and 
AA (50 M each) for 24 h. The protein levels of HO-1, NQO1 and Nrf2 were 
analyzed by Western blot analysis. (E) MEF cells were transiently transfected 
with nrf2 siRNA or control siRNA for 48 h and were incubated with or without 










Table 3-2. PUFA composition in mouse embryonic fibroblasts (MEFs) from 
fat-1 transgenic and wild-type mice 
   WT MEF fat-1+/− MEF 
Linoleic acid  C18:2 2.95 ± 0.08  1.51 ± 0.01c 
γ-Linolenic acid  C18:3 0.07 ± 0.01 0.03 ± 0.01a 
Arachidonic acid  C20:4 6.24 ± 0.13 3.89 ± 0.06c 
ω-6 PUFAs (%)   9.26 ± 0.21 5.44 ± 0.05c 
α-Linolenic acid   C18:3 0.17 ± 0.01  0.37 ± 0.03b 
Eicosapentaenoic acid  C20:5 0.44 ± 0.01  1.56 ± 0.21b 
Docosahexaenoic acid   C22:6 0.74 ± 0.02  2.67 ± 0.22c 
ω-3 PUFAs (%)   1.35 ± 0.02  4.60 ± 0.08c 
ω-6/ω-3 PUFAs   6.85 ± 0.10  1.19 ± 0.01c 
ω-3/ω-6 PUFAs   0.15 ± 0.003  0.85 ± 0.01c 
Data are expressed as means ± SE (n = 3). 




Fig. 3-8. DHA increased the stability of Nrf2 protein in mouse epidermal 
JB6 cells. (A) JB6 cells were transfected transiently for 24 h with expression 
plasmids for pCMV-HA-mock or pCMV-HA-fat-1. Transfected cells were 
treated with or without LA and AA (25 μM) for 48 h prior to the RT-PCR and 
Western blot analysis to determine the levels of Nrf2 and cytoprotective 
proteins. Transfection with pCMV-HA-fat-1 increased protein expression of 
Nrf2 without altering its mRNA transcriptional level in JB6 cells. (B, C) JB6 
cells were challenged with 0.1 mg/mL cycloheximide for the indicated times or 
MG-132 (20 μM) for 30 min in the absence or presence of 50 μM of DHA for 
８５ 
6 h. Western blot analysis was performed for detecting Nrf2 levels. (D) After 
treatment of JB6 cells with DHA (50 μM) in the absence or presence of AA (25 
μM) for 6 h, 500 μg of proteins was immunoprecipitated with anti-Nrf2 

















A wide variety of natural anti-inflammatory and anti-oxidative agents which 
are constituents of our daily diet have been demonstrated to combat skin cancer 
triggered by UVB irradiation (Chapkin et al. 2009, Mittal et al. 2003, Singh et 
al. 2006, Staniforth et al. 2006b, Won et al. 2004). Mounting evidence from 
epidemiological and laboratory-based studies suggest that -3-PUFAs, present 
in fish oil and plant seed oil, possess a broad range of health beneficial 
properties (Jho et al. 2004) and exert protective effects against oxidative stress-
induced disease processes, such as inflammation (Kang & Weylandt 2008), 
aging (Lukiw & Bazan 2008) and cancer (Rose & Connolly 1999). DHA, one 
of the major ω-3-PUFAs, has been reported to inhibit UVB-induced 
inflammatory and oxidative responses in mouse skin (Rahman et al. 2011). 
Rahman et al. have demonstrated that topical application of DHA inhibited 
UVB-induced expression of COX-2 and that of NAD(P)H oxidase-4, an 
enzyme involved in the generation of ROS, in hairless mouse skin (Rahman et 
al. 2011). These findings are in good agreement with the previously published 
anti-inflammatory and anti-oxidative effects of this compound (Chen et al. 
2013, Sunada et al. 2006). 
Meanwhile, the present study also examines the chemopreventive effects of 
endogenously produced ω-3 PUFAs against photocarcinogenesis using fat-1 
transgenic mice without the need of supplementation with exogenous ω-3 
PUFAs. Modification of the tissue ω-6/ω-3 fatty acid ratio by increasing ω-3 
８７ 
fatty acid levels and decreasing ω-6 fatty acid levels may be an effective 
therapeutic approach, because this will not only reduce the ω-6-derived tumor-
promoting eicosanoids but also increase the formation of ω-3-derived anti-
tumor eicosanoids. Experimental data have already showed that the efficacy of 
ω-3 PUFAs in suppressing cancer growth depends not only on the amount of 
ω-3 PUFAs but also on background levels of ω-6 PUFAs (Bougnoux 1999). 
Homozygous mutations in hairless gene cause a permanent hair loss, referred 
to as alopecia in both humans and mice (Panteleyev et al. 1999). The hairless 
animals are used historically as a convenient mouse model to study skin 
carcinogenesis (Benavides et al. 2009). To enhance susceptibility to both 
cutaneous inflammation and papilloma development, we have generated 
hairless fat-1−/− and fat-1+/− mice by cross-breeding of male fat-1+/− transgenic 
mice with female SKH-1 hairless mice. The present study showed that an 
inflammatory response in the hairless fat-1+/− mice was significantly lower than 
in the hairless fat-1−/− mice thereby subsequently reducing the susceptibility to 
UVB-induced papilloma formation. 
Recently, COX-2 has been identified as a molecular link between 
inflammation and tumor promotion (Kundu & Surh 2005). COX-2 has been 
upregulated in various cells in culture or in mouse skin in vivo after irradiation 
with UVB (Cho et al. 2005, Tang et al. 2001b, Bachelor et al. 2005, Staniforth 
et al. 2006a, Tang et al. 2001a). Elevated expression of COX-2 observed in 
mouse skin papillomas formed after chronic exposure to UVB (An et al. 2002, 
Won et al. 2004). A number of animal models have shown that inhibition of 
８８ 
COX-2 by biochemical inhibitors or genetic deletion helps suppress chemical- 
or UVB-induced skin tumor development (Tiano et al. 2002, Wright et al. 2006). 
Oral or topical administration of celecoxib, a COX-2 inhibitor, has been 
reported to prevent new tumor formation after the onset of UVB-induced 
photocarcinogenesis in hairless mice (Wilgus et al. 2003). In the present study, 
the stimulation of hairless mice with UVB (180 mJ/cm2) until 23 weeks resulted 
in a significant increase in COX-2 expression. Hairless fat-1+/− mice capable of 
spontaneously producing ω-3 PUFAs exhibited significantly reduced 
expression of COX-2 compared with those from hairless fat-1−/− mice, and were 
protected from UVB-induced photocarcinogenesis. These findings suggest that 
ω-3 PUFAs could be potential candidates for chemoprevention of 
inflammation-associated carcinogenesis. 
Our in vivo data showed that enhanced inflammatory response regulated 
tumor progression via activation of the transcription factor STAT3 in UVB-
irradiated skin of hairless mice. A critical role of STAT3 in promoting 
proliferation, metastasis and immune evasion of tumor cells has been shown in 
various pathophysiologic conditions (Yu & Jove 2004). Kim et al. reported that 
constitutive activation of STAT3 enhanced UVB-induced skin carcinogenesis 
(Kim et al. 2009a). Likewise, STAT3 activation promoted keratinocyte survival 
and proliferation in response to UVB radiation (Sano et al. 2005). Thus, 
inhibition of aberrant STAT3 signaling is considered as a pragmatic approach 
for achieving the prevention of skin cancer. In this study, the repeated UVB 
irradiation caused Tyr705 phosphorylation of STAT3 in the skin papillomas and 
８９ 
this was attenuated in fat-1+/− mice. 
ROS-mediated oxidative stress is capable of fostering the development of 
various pathological conditions mainly by overwhelming skin homeostatic 
defenses. Body protects against oxidative stress and maintains the reduced state 
of cells through activation of a series of antioxidant enzymes, such as HO-1 and 
NQO1 (Surh et al. 2008). In line with this notion, WT mice exhibit relatively 
reduced multiplicity of skin papillomas as compared to HO-1 knockout animals 
at the early stage of skin carcinogenesis (Was et al. 2011). Likewise, NQO1-
null mice were more sensitive to chemically induced skin tumorigenesis as 
compared to WT mice (Long et al. 2000, Long et al. 2001). Nrf2 plays a 
fundamental role in regulatory expression of many anti-oxidative and 
cytoprotective proteins including HO-1 and NQO1. Nrf2 knockout mice were 
more susceptible to develop chemically induce skin tumors (Xu et al. 2006). In 
our results, one of the notable changes accompanying a lower level of oxidative 
stress related hallmarks and the reduction of papilloma formation by UVB 
irradiation was the Nrf2-mediated induction of cytoprotective gene expression 
in the skin tissues of fat-1 mice. 
Since DHA, a prototypic -3 PUFA, exhibited pronounced induction of HO-
1 and NQO1 in vitro (Yang et al. 2013), we sought to explore the mechanistic 
basis of anti-oxidative effects of an elevated -3-PUFA level in subsequent 
experiments using the fat-1 MEFs. In order to delineate the molecular 
mechanisms underlying the induction of HO-1 and NQO1, we examined the 
activation of Nrf2 in the fat-1 MEFs. The inhibition of HO-1 and NQO1 
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expression in the Nrf2 siRNA-transfected fat-1 MEFs suggests that the 
expression of HO-1 and NQO1 was induced mainly through upregulation of 
Nrf2 signaling in the fat-1 MEFs. Furthermore, DHA enhanced stabilization of 
Nrf2 protein by inhibiting ubiquitination and 26S proteasomal degradation in 
the JB6 cells. The downregulation of Nrf2 ubiquitination and subsequent 26S 
proteasomal degradation through disruption of the protein-protein interaction 
present in Cullin3-Rbx1 E3 ligase complex is generally accepted (Villeneuve 
et al. 2010). As little is known about the mechanisms by which dietary 
phytochemicals such as DHA leads to Nrf2 activation by targeting ubiquitin 
ligase complex, much more precise experiments are required. 
Nrf2 is normally sequestered in the cytoplasm as an inactive complex with 
its cytosolic repressor, named Kelch-like ECH associated protein 1 (Keap1) 
(Lee & Surh 2005, Surh et al. 2008). An early independent study suggested that 
modification of Keap1 cysteines by ARE inducers directly disrupts the 
interaction between Keap1 and Nrf2 (Dinkova-Kostova et al. 2002). However, 
subsequent experiments demonstrated that in fact the disruption of the Keap1-
Nrf2 complex does not occur upon modification of Keap1 cysteines (Eggler et 
al. 2005). While modification of Keap1 cysteines does not alter the affinity of 
Keap1 for Nrf2, recent data indicate that the Keap1-Cullin3 interaction is 
altered (Zhang et al. 2004a, Gao et al. 2007). These results suggested that 
reaction of Nrf2 activators with Keap1 cysteines leads to a reduced association 
between Keap1 and Cullin3, thereby downregulating Nrf2 ubiquitination. This 
would lead to Nrf2 accumulation and increased expression of cytoprotective 
９１ 
proteins. Therefore, whether the activation of Nrf2 by DHA is mediated through 
direct interaction of DHA or its electrophilic metabolites with Nrf2 inhibitory 
protein Keap1 merits further investigation. 
In conclusion, the present study demonstrates that constitutive ω-3 fatty acid 
production in the fat-1 mice protects against UVB-induced papillomagenesis 
through the downregulation of STAT3 activation, inhibition of lipid 
perdoxidation and upregulation of cytoprotective proteins. These results may 
offer practical and feasible approaches for the prevention of skin disorders 


















Constitutive ω-3 fatty acid production in fat-1 transgenic 
mice and docosahexaenoic acid administration to wild 











Omega-6 (ω-6) and omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) are 
known to have opposite effects on the inflammatory process. In general, ω-6 
PUFAs are pro-inflammatory, whereas ω-3 PUFAs possess anti-inflammatory 
as well as anti-oxidative activity. In the present study, we investigated the 
protective effects of ω-3 PUFAs on experimentally induced murine colitis. 
Intrarectal administration of 2.5% 2,4,6-trinitrobenzene sulfonic acid (TNBS) 
caused inflammation in the colon of wild type mice, but this was less severe in 
fat-1 transgenic mice that constitutively produce ω-3 PUFAs from ω-6 PUFAs. 
The intraperitoneal administration of docosahexaenoic acid (DHA), a 
representative ω-3 PUFA, was also protective against TNBS-induced murine 
colitis. In addition, endogenously formed and exogenously introduced ω-3 
PUFAs attenuated lipid peroxidation (malondialdehyde) and protein oxidation 
(4-hydroxy-2-nonenal) in the colon of TNBS-treated mice. The effective 
protection against inflammatory and oxidative colonic tissue damages in fat-1 
and DHA-treated mice was associated with suppression of nuclear factor-kappa 
B activation and cyclooxygenase-2 expression and with elevated activation of 
nuclear factor erythroid-related factor 2 and upregulation of its target gene, 
heme oxygenase-1. Taken together, these results provide mechanistic basis of 
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Inflammatory bowel diseases (IBD) are chronically relapsing disorders of the 
colon and small intestine (Binder 2004). Their pathogenic features involve 
dysregulation of the intestinal immune response, characterized by T cell-rich 
infiltrates and overproduction of reactive oxygen species (ROS) in the inflamed 
mucosa of the terminal ileum and colon, where many intestinal microbes reside 
(Rafii et al. 1999, Atreya et al. 2000). Altered intestinal microflora and ROS 
overproduction may contribute to initiation and perpetuation of colonic 
inflammation. Intestinal bacterial endotoxins, such as lipopolysaccharides, 
penetrate the epithelial barrier and directly stimulate the mucosal immune 
system (Rafii et al. 1999, Radema et al. 1991). This results in the production of 
pro-inflammatory cytokines and other inflammatory mediators, which act 
through Toll-like receptors or cytokine receptors (Jung et al. 1997, Chow et al. 
1999, Cario & Podolsky 2000). Recently, a better understanding of the 
mechanisms involved in pathogenesis of IBD has been achieved with the 
animal models of intestinal inflammation. 2,4,6-Trinitrobenzenesulfonic acid 
(TNBS)-induced colitis in mice is one such animal model that mimics the 
human IBD and is hence utilized in preclinical studies (Neurath et al. 2000, 
Wirtz & Neurath 2007, Wirtz et al. 2007). 
Polyunsaturated fatty acids (PUFAs) are important as structural components 
of membrane phospholipids and as precursors of families of intracellular 
signaling molecules, including eicosanoids (Lands 1987, Samuelsson et al. 
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1987, James et al. 2000). The eicosanoids derived from omega-6 (ω-6) and 
omega-3 (ω-3) PUFAs are functionally distinct, and some have opposing 
physiological functions (James et al. 2000, Calder 1997). For example, 
eicosanoids derived from the ω-6 PUFA arachidonic acid, such as prostaglandin 
E2 and leukotriene B4, have been shown to promote formation, growth, and 
metastasis of cancer cells (Haeggstrom 2004, Kunikata et al. 2005), whereas 
those from ω-3 PUFAs have suppressive effects (Calder 1997, Rose & Connolly 
2000, Karmali 1987, Nie et al. 2000, Ge et al. 2002, Yang et al. 2004). It has 
been shown that the health benefit of dietary ω-3 PUFAs is most prominent 
when its proportion exceeds substantially that of ω-6 PUFAs (Cave 1997, 
Belluzzi et al. 1996, Endres et al. 1999, Stenson et al. 1992). According to 
recent findings (Simopoulos 2000, Leaf & Weber 1987), the ratio of ω-6 to ω-
3 PUFAs in modern diet is approximately 20:1. This may account for the 
increased incidence of inflammatory diseases (Simopoulos 2000, Leaf & Weber 
1987) including IBD in Western societies where diets are largely deficient in ω-
3 PUFAs (Shoda et al. 1996, Tragnone et al. 1995). Thus, balancing the tissue 
ratio of ω-6 to ω-3 fatty acids may be a feasible approach to the control of many 
inflammation-associated disorders. 
Kang et al. generated transgenic mice carrying a fat-1 gene which encodes 
desaturase (Kang et al. 2004). Unlike the wild type (WT) littermates, these mice 
can convert ω-6 to ω-3 PUFAs. Different tissues of fat-1 mice show a marked 
increase in ω-3 PUFAs and decrease in ω-6 PUFAs (Kang et al. 2004). For 
instance, fat-1 transgenic mice fed diet containing ω-6 PUFAs had significantly 
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higher amounts of ω-3 PUFAs in the colonic tissues compared with those in 
WT mice (Hudert et al. 2006). Thus, the fat-1 transgenic mice offer a model for 
investigating the importance of the ratio of ω-6/ω-3 PUFA in the management 
of many inflammation-associated disorders. In the present study, we 
investigated the beneficial effect of endogenously produced ω-3 fatty acids in 
fat-1 transgenic mice on the development of experimentally induced colitis. In 
a series of parallel experiments, effects of exogenously administered 













3. Materials and Methods 
Animals and diets 
fat-1 transgenic mice were backcrossed onto a the C57BL/6 background 
(Charles River Laboratories, Wilmington, MA). The tails of offsprings were 
subjected to genotyping to verify the fat-1  heterozygosity using the Tissue-
DirectTM PCR Kit (Lamda Biotech, Inc. St. Louis, MO). The genotyping 
primers were as follows: 5’-CTG CAC CAC GCC TTC ACC AAC C-3’ 
(forward) and 5’-ACA CAG CAG CAG ATT CCA GAG ATT-3’ (reverse). 
Male heterozygous fat-1 mice were used in our study and were housed in plastic 
cages under controlled conditions of temperature (23 ± 2°C), humidity (50 ± 
10%) and light (12/12 h light/dark cycle). They fed a 10% safflower oil diet 
high in ω-6 and low in ω-3 fatty acids until the desired age (8–9 weeks). The 
studies were approved by the Institutional Animal Care and Use Committee of 
Seoul National University. 
 
Induction of TNBS-induced colitis 
Both WT and transgenic mice were anaesthetized with ketamine and xylazine. 
Colitis was induced by intrarectal administration of 2.5% TNBS (Sigma 
Aldrich, St. Louis, MO) in 50% ethanol via a thin round-tip needle equipped 
with a 1 ml syringe, and the animals were then kept in a vertical position for 30 
seconds. The total injection volume was 100 μl. To evaluate the prophylactic 
effect of DHA (Cayman Chemical Co., Ann Arbor, MI), the TNBS colitis mice 
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were injected intraperitoneally with 200 μl of phosphate-buffered saline (PBS) 
or DHA (4 mg/kg body weight) for 7 days before induction of colitis and 
thereafter until the end of the study. The defecation pattern and the body weight 
change were monitored daily to see any inflammation signs. The mice were 
sacrificed 3 days after TNBS administration. The colons were removed, opened 
longitudinally and cleared of the fecal matter with PBS. Immediately after 
washing, an inflamed segment was cut for histopathological examination, 




Specimens of the colon fixed with 10% buffered formalin were embedded in 
paraffin. Each section (4 μm) was stained with hematoxylin and eosin (H&E). 




The dissected colon tissues were prepared for immunohistochemical analysis 
of the expression patterns of 4-hydroxy-2-nonenal (4-HNE)- or 
malondialdehyde (MDA)-modified protein, cyclooxygenase-2 (COX-2), 
nuclear factor-kappa B (NF-κB) p65 and nuclear factor erythroid-related factor 
2 (Nrf2). Four-μm sections of 10% formalin-fixed, paraffin-embedded tissues 
were cut on silanized glass slides, deparaffinized three times with xylene and 
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rehydrated through graded alcohol bath. The deparaffinized sections were 
heated by using microwave and boiled twice for 6 min in 10 mM citrate buffer 
(pH 6.0) for antigen retrieval. To diminish nonspecific staining, each section 
was treated with 3% hydrogen peroxide and 4% peptone casein blocking 
solution for 15 min. For the detection of respective protein expression, slides 
were incubated with proteins modified with 4-HNE or MDA (JaICA, Nikken 
SEIL Co. Ltd., Shizuoka, Japan), COX-2 (Cayman Chemical Co., Ann Arbor, 
MI), NF-κB p65 and Nrf2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) 
antibodies at room temperature for 40 min in Tris-buffered saline containing 
0.05% Tween 20, and then developed using horseradish peroxidase-conjugated 
secondary antibodies (rabbit or mouse) (Dako, Glostrup, Denmark). The 
peroxidase binding sites were detected by staining with 3,3’-diaminobenzidine 
tetrahydrochloride. Finally, counterstaining was performed using Mayer’s 
hematoxylin. 
 
Tissue lysis and protein extraction 
Colon tissues were homogenized in ice-cold lysis buffer [150 mM NaCl, 0.5% 
Triton-X 100, 50 mM Tris–HCl (pH 7.4), 20 mM ethylene glycol tetra-acetic 
acid, 1 mM dithiothreitol (DTT), 1 mM Na3VO4 and protease inhibitors, 1 mM 
phenylmethyl sulfonylfluoride (PMSF) and ethylenediaminetetraacetic acid 
(EDTA)-free cocktail tablet] followed by periodical vortex for 30 min at 0°C. 
Lysates were centrifuged at 14,800 g for 15 min at 4°C. Supernatants were 
collected and stored at -70°C until use. 
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Preparation of cytosolic and nuclear extracts 
Cytosolic extracts were obtained from lysates dissolved in hypotonic buffer A 
[10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 7.8), 
1.5 mM MgCl2, 10 mM KCl, 1 mM DTT, 0.1 mM EDTA and 0.1 mM PMSF] 
with 10% Nonidet P-40 (NP-40) by homogenization and vortex-mixing at 10 
min intervals for 3 h. After centrifugation at 14,800 g for 15 min, the 
supernatants (the cytosolic extracts) were collected and stored at -70°C until 
use. Precipitated pellets were washed with buffer A plus 10% NP-40 three times 
to remove remaining cytosolic components. Pellets were then resuspended in 
buffer C [50 mM HEPES, pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 
1 mM DTT, 0.1 mM PMSF and 20% glycerol]. After centrifugation at 14,800 
g for 15 min, the supernatants (nuclear extracts) were collected and stored at -
70°C until use. 
 
Western blot analysis 
For Western blot analysis, the total protein concentration was quantified by 
using the bichinconinic acid protein assay kit (Pierce, Rockford, IL). Cell 
lysates (30 μg protein) were mixed and boiled in sodium dodecyl sulfate (SDS) 
sample buffer for 5 min before 8-15% SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE). They were separated by SDS-PAGE and transferred to a 
polyvinylidene difluoride membrane (Gelman Laboratory, Ann Arbor, MI). The 
blots were blocked in 5% fat-free dry milk in tris-buffered saline containing 0.1% 
１０２ 
tween 20 (TBST) for 1 h at room temperature. The membranes were incubated 
for 12-24 h at 4°C with dilutions of primary antibodies for proteins modified 
with 4-HNE (JaICA, Nikken SEIL Co. Ltd., Shizuoka, Japan), COX-2 
(Cayman Chemical Co., Ann Arbor, MI), actin (Sigma Aldrich, St. Louis, MO), 
α-tubulin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), lamin B 
(Invitrogen, Carlsbad, CA), P-IκBα, p65 (Cell Signaling Technology, Danvers, 
MA), heme oxygenase-1 (HO-1) (Stressgen Biotechnologies Co., San Diego, 
CA), and Nrf2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Membranes 
were washed followed by incubation with 1:3000 dilutions of respective 
horseradish peroxidase-conjugated secondary antibodies (rabbit or mouse) 
(Zymed Laboratories Inc., San Francisco, CA) for 2 h and again washed with 
TBST. Protein expressed was visualized with an enhanced chemiluminescent 
(ECL) detection kit (Amersham Pharmacia Biotech, Buckinghamshire, UK) 
and LAS-4000 image reader (Fujifilm, Tokyo, Japan) according to the 
manufacturer’s instructions. 
 
Reverse transcription-polymerase chain reaction analysis (RT-PCR) 
Total RNA was isolated from mouse colon tissues using TRIzol® reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. To 
generate the cDNA from RNA, 1 µg of total RNA was reverse transcribed with 
murine leukemia virus reverse transcriptase (Promega, Madison, WI) for 50 
min at 42°C and again for 15 min at 72°C. About 1 μl of cDNA was amplified 
with a PCR mixture (HS Prime Taq 2X Premix, Daejeon, South Korea) in 
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sequential reactions. The primers used for each RT-PCR reactions are as follows: 
cox-2, 5’-CTG GTG CCT GGT CTG ATG ATG-3’ and 5’-GGC AAT GCG 
GTT CTG ATA CTG-3’; actin, 5’-AGA GCA TAG CCC TCG TAG AT-3’ and 
5’-CCC AGA GCA AGA GAG GTA TC-3’; ho-1, 5’-TAC ACA TCC AAG 
CCG AGA AT-3’ and 5’-GTT CCT CTG TCA GCA TCA CC-3’; nrf2, 5’-CCT 
CTG TCA CCA AGC TCA AGG-3’ and 5’-TTC TGG GCG GCG ACT TTA 
TT-3’ (forward and reverse, respectively). Amplification products were 
analyzed by 2-3% agarose gel electrophoresis, followed by staining with SYBR 
Green (Invitrogen, Carlsbad, CA) and photographed using fluorescence in 
LAS-4000 (Fujifilm, Tokyo, Japan). 
 
Statistical analysis 
All the values were expressed as the mean ± standard error (SE) of at least three 
independent experiments. Statistical significance was determined by the 









fat-1 transgenic and DHA-treated WT mice were protected from TNBS-
induced colonic inflammation 
An increased ω-3 PUFA tissue status in fat-1 transgenic mice conferred 
effective protection against colitis caused by TNBS injection. Thus, fat-1 mice 
exhibited body weight reduction and shortening of the colorectal length caused 
by TNBS to a lesser extent than the WT mice (Fig. 4-1A and B). There were 
significant differences between TNBS-treated WT and fat-1 transgenic mice in 
the bowel habit as well as in the gross findings of colon (Fig. 4-1C and D). 
Histopathological analysis showed that TNBS administration completely 
disrupted the architecture of colonic mucosa as evidenced by distortion of 
crypts, loss of goblet cells and infiltration of mononuclear cells. These 
abnormalities were significantly alleviated in fat-1 transgenic mice (Fig. 4-1E). 
According to the previously reported PUFA profiles of the colonic tissues of 
fat-1 transgenic mice, DHA is the most predominant ω-3 PUFA (Hudert et al. 
2006). Therefore, we also investigated the protective potential of DHA 
administered in WT mice which were subjected to TNBS-induced colitis. As in 
the case of fat-1 transgenic mice, WT mice administered DHA were protected 
from TNBS-induced colitis (Fig. 4-2). 
 
TNBS-induced oxidative colonic tissue damage was ameliorated in fat-1 and 
DHA-treated mouse colon 
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Oxidative stress has been implicated in the pathogenesis of human IBD and 
experimentally induced colitis. Sustained elevation of ROS production in IBD 
by activated phagocytic leukocytes, the xanthene oxidase activity and oxidation 
of arachidonic acid overwhelms the endogenous antioxidant defense, and this 
leads to oxidative tissue injury, causing impairment in membrane stability and 
cell death (McKenzie et al. 1996). Instillation of TNBS causes production of 
ROS, initiating and perpetuating colonic inflammation (Liu & Wang 2011). 
Some reactive aldehydes, such as 4-HNE and MDA, are produced as the 
secondary products of ROS-mediated lipid peroxidation (Ayala et al. 2014, 
Negre-Salvayre et al. 2008). As shown in Fig. 4-3A and B, the levels of MDA- 
and 4-HNE-modified proteins were much lower in the colonic tissues of fat-1 
mice than that in WT animals. Likewise, DHA treatment attenuated oxidative 
colonic tissue damage as demonstrated by the reduced expression of 4-HNE-
modified protein (Fig. 4-3C and D). 
 
TNBS-induced expression of COX-2 was decreased in fat-1 and DHA-treated 
mouse colon 
Increased expression of the pro-inflammatory enzyme, COX-2 is often 
observed in the inflamed colonic mucosa of patients with IBD (Wang & Dubois 
2010b) as well as TNBS-induced colitis in animals (Paiotti et al. 2009, Zhang 
et al. 2004b). To assess whether protection of fat-1 and DHA-treated mice 
against TNBS-induced colonic inflammation involves alteration in expression 
of COX-2, tissue samples were analyzed by RT-PCR and immunoblot analysis. 
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The mRNA and protein expression levels of COX-2 were markedly diminished 
in fat-1 transgenic mice (Fig. 4-4A). Immunohistochemical analysis further 
confirmed the inhibitory effect of endogenously formed ω-3 PUFAs on TNBS-
induced COX-2 expression in the fat-1 mouse colon (Fig. 4-4B). DHA 
administration also inhibited the expression of COX-2 in the colon of TNBS-
treated mice (Fig. 4-4C and D). 
 
TNBS-induced NF-κB activation was diminished in the colonic mucosa of 
fat-1 and DHA-treated mice 
NF-κB is one of the representative redox-sensitive transcription factors that 
plays a key role in intracellular inflammatory signal transduction. Concordant 
with the reduced ROS-mediated oxidative stress in fat-1 mouse colon (Fig. 4-
3), there was a substantial decrease in NF-κB activation upon TNBS treatment. 
Activation of NF-κB is dependent on its dissociation from the inhibitory protein 
IκBα, which requires phosphorylation of the latter protein. We determined the 
level of phosphorylated IκBα in the colon of mice injected with TNBS. As 
shown in Fig. 4-5A and C, fat-1 and DHA-treated mice exhibited a significant 
reduction of TNBS-induced IκBα phosphorylation at the serine 32/36 residue 
and its subsequent degradation in the colonic mucosa. In addition, TNBS 
treatment induced nuclear translocation of p65, the functionally active subunit 
of NF-κB, which was dampened in fat-1 (Fig. 4-5A) and DHA-treated (Fig. 4-
5C) mice. A significantly lower intensity of p65 immunostaining was also 
observed in the colonic tissues from fat-1 and DHA-treated mice, as compared 
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with WT control mice (Fig. 4-5B and D). 
 
The protein level of Nrf2 and its nuclear translocation were increased in the 
colon of fat-1 and DHA-treated mice 
NF-κB activation is mediated by ROS to some extent, and antioxidant enzymes 
can attenuate inflammatory as well as oxidative tissue damage (Kundu & Surh 
2010). Nrf2 is a prime transcription factor that plays a key role in regulating the 
expression of antioxidant genes, such as HO-1. There was a robust induction of 
Nrf2-mediated HO-1 expression in fat-1 mouse colon (Fig. 4-6A and B). 
Although the colonic mRNA expression levels of Nrf2 were not much different 
between WT and fat-1 mice (Fig. 4-6A), its protein expression was significantly 
elevated by endogenous production of ω-3 PUFAs in the latter animals (Fig. 4-
6B). The nuclear translocation of Nrf2 was also augmented in colonic tissues 
of fat-1 mice as compared to that of WT mice (Fig. 4-6B). We attempted to 
evaluate the anti-oxidative effects of DHA in terms of nuclear accumulation of 
Nrf2 in the colonic mucosa, and a significant difference was found between 
control and DHA-treated mice (Fig. 4-6C). The increased expression of Nrf2 
in the colons of DHA-treated mice was verified by immunohistochemical 
analysis (Fig. 4-6D). 
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Fig. 4-1. TNBS-induced colonic inflammation was less severe in fat-1 
transgenic mice than that in WT mice. Male WT and fat-1 transgenic mice 
were anaesthetized with ketamine and xylazine, and colitis was induced by 
intrarectal administration of TNBS (2.5% in 50% ethanol). The comparison of 
(A) body weight change and (B) colon length at day 3 in WT and fat-1 mice 
after TNBS exposure. Results are expressed as means ± SE (n = 3 for each 
group). *p <0.05 versus TNBS-treated WT mice. (C) Representative 
photographs of the mouse colon in WT and fat-1 transgenic mice with and 
without TNBS treatment. (D) Macroscopic view of the mouse colon in WT and 
fat-1 mice. (E) Representative distal colon sections stained with H&E. 
Magnifications; ×100.  
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Fig. 4-2. DHA administration ameliorated pathological symptoms in a 
TNBS-induced murine colitis model. Male C57BL/6 mice were injected 
intraperitoneally with DHA (4 mg/kg body weight) for 7 days before induction 
of TNBS colitis and thereafter until the end of the study. The comparison of (A) 
body weight change and (B) colon length at day 3 in mice after TNBS exposure. 
Data are expressed as means ± SE (n = 3 for each group). **p <0.01 versus 
TNBS-treated control mice. (C) Representative photographs and (D) 
macroscopic view of the mouse colon in control, TNBS-treated, DHA (4 
mg/kg)-treated, and DHA (4 mg/kg) plus TNBS-treated group. (E) 




Fig. 4-3. TNBS-induced oxidative colonic tissue damage was attenuated in 
fat-1 and DHA-treated mice. (A) Western blot analysis of 4-HNE-modified 
protein expression in the colon strips of WT and fat-1 mice. Results are 
expressed as means ± SE (n = 3, in each group). **Significantly different from 
TNBS-treated WT mice (p <0.01). (B) Immunohistochemical detection of 4-
HNE- and MDA-modified proteins (brown spots) in mouse colon. 
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Magnifications; ×100. (C) 4-HNE levels in the colonic mucosa of control and 
DHA-treated mice. *p <0.05 versus TNBS-treated control mice. (D) A 
representative photomicrograph showing 4-HNE immunopositive cells in 





Fig. 4-4. TNBS-induced colonic expression of COX-2 was decreased in fat-
1- and DHA-treated mice compared with that in WT control mice. (A) RT-
PCR and Western blot analysis of COX-2 in colon strips of WT control mice, 
TNBS-treated WT littermates, fat-1 transgenic mice, and TNBS-treated fat-1 
littermates. Data are expressed as means ± SE (n = 3 for each group). **p <0.01 
and ***p <0.001 versus TNBS-treated WT mice. (B) Immunohistochemical 
detection of COX-2 (brown spots) in mouse colon. Magnifications; ×100. (C) 
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The mRNA and protein levels of COX-2 in colon strips of control, TNBS-
treated, DHA (4 mg/kg)-treated, and DHA (4 mg/kg) plus TNBS-treated mice. 
**p <0.01 and ***p <0.001 versus TNBS-treated WT control mice. (D) The 
respective sections were immunostained for COX-2 and counterstained with 





Fig. 4-5. TNBS-induced NF-κB activation was diminished in the colonic 
tissues of fat-1 and DHA-treated mice compared with that in the WT 
control mouse colon. (A) Colonic NF-κB activation in terms of cytosolic P-
IκBα (Ser32/36) and nuclear p65 levels was assessed by Western blot analysis. 
Results are expressed as means ± SE (n = 3, in each group). *p <0.05 and **p 
<0.01 versus TNBS-treated WT mice. (B) Immunohistochemical analysis of 
p65 expression. Magnifications; ×100. (C) P-IκBα (Ser32/36) and p65 levels in 
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the supernatants of colon strips of colon strips of control, TNBS-treated, DHA 
(4 mg/kg)-treated, and DHA (4 mg/kg) plus TNBS-treated mice. *p <0.05 
versus TNBS-treated control mice. (D) Immunohistochemical detection of p65 
(brown spots) in the control, TNBS alone, DHA (4 mg/kg) alone, and DHA (4 







Fig. 4-6. The protein levels of Nrf2 and its nuclear translocation were 
increased in the colon of fat-1 and DHA-treated mice. (A) RT-PCR analysis 
of mRNA expression of ho-1 and nrf2 in WT mice and fat-1 littermates. (B) 
Western blot analysis of HO-1 and Nrf2 levels in the colon strips of WT and 
fat-1 transgenic mice. Data are expressed as means ± SE (n = 3 for each group). 
**p <0.01 and ***p <0 .001 versus WT animals. (C) Nrf2 levels in the nuclear 
fraction of colon strips of control and DHA-treated mice. *p <0.05 versus 
control animals. (D) Immunohistochemical detection of Nrf2 (brown spots) in 
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mouse colon. Magnifications; x100. The experimental conditions are described 






















The advent of animal models of mucosal inflammation in the colon has helped 
researchers a better understanding of the mechanisms involved in intestinal 
homeostasis and pathogenesis of IBD. TNBS-induced colitis is a well-
established animal model of mucosal inflammation and resembles human 
Crohn’s disease in regard to many features, both histologically and 
immunologically (Neurath et al. 2000, Wirtz & Neurath 2007, Wirtz et al. 2007). 
In the present study, fat-1 transgenic and DHA-treated WT mice were protected 
from TNBS-induced colonic inflammation. The protection from TNBS-
induced colitis in fat-1 and DHA-treated mice were associated with regulation 
of the redox-sensitive transcription factors NF-κB and Nrf2 in the colonic 
mucosa of these animals. NF-κB and Nrf2 regulate pro- and anti-inflammatory 
gene expression, respectively in a cooperative way (Cuadrado et al. 2014). 
Therefore, proper modulation of NF-κB and Nrf2 signaling is considered an 
effective strategy in the management of disorders tied to inflammation and 
oxidative stress. 
Evidence for the involvement of COX-2 in colonic inflammation came from 
the observations that selective inhibitors of this enzyme reduced the severity of 
the symptoms in the animal model of TNBS-induced colitis (Paiotti et al. 2009, 
Kruschewski et al. 2006) as well as patients with Crohn’s disease (McCartney 
et al. 1999). Thus, inhibition of the abnormally elevated expression or activity 
of COX-2 appears to be an effective approach to the prevention and treatment 
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of IBD. In the present study, fat-1 mice capable of spontaneously producing ω-
3 PUFAs and DHA-treated mice exhibited significantly reduced colonic 
expression of COX-2 compared with those from WT control animals, and were 
protected from TNBS-induced colitis. Considering COX-2 as a principal 
molecular link between inflammation and cancer (Williams et al. 1999), these 
findings suggest that ω-3 PUFAs could be potential candidates for 
chemoprevention of inflammation-associated colon carcinogenesis. 
Our present study demonstrates decreased phosphorylation of IκBα and 
nuclear translocation of p65, two key events in NF-κB signaling, in fat-1 and 
DHA-treated mice, which account for their protection from TNBS-induced 
colitis. ω-3 PUFAs undergo both enzymatic and non-enzymatic conversion, 
some of resulting products have powerful anti-inflammatory and proresolving 
activities (Yum et al. 2016). Examples are resolvins and protectins, endogenous 
ω-3 PUFA-derived lipid mediators (Kohli & Levy 2009, Serhan et al. 2008). It 
will be worthwhile evaluating the protective effects of these endogenous anti-
inflammatory and proresolving substances on experimentally induced colitis 
and colon carcinogenesis. In this context, it is noticeable that resolvin E1 
protects against TNBS-induced colitis (Arita et al. 2005). 
The inflammatory process not only induces NF-κB activation but also 
generates ROS and related products, such as superoxide anion, hydrogen 
peroxide, 4-HNE, and hypochlorous acid, which are involved in the 
pathogenesis of IBD (Kruidenier et al. 2003, Naito et al. 2007). We observed 
in the present study that TNBS significantly increased accumulation of 4-HNE 
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and MDA as well as NF-κB activation in the colon of mice intrarectally injected 
with TNBS. Furthermore, it has been reported that treatment with superoxide 
dismutase significantly ameliorates TNBS-induced colitis (Han et al. 2006). 
The results of the present study support a role for ω-3 PUFAs in the preservation 
of the intestinal epithelial barrier as demonstrated by higher levels of the anti-
oxidative Nrf2 and its target gene, ho-1 in the colon mucosa of fat-1 transgenic 
and DHA-treated mice. Thus, potentiation of cyprotective capacity in the ω-3 
PUFA-enriched tissues may be one of the underlying mechanisms responsible 
for the protection against ROS-induced oxidative damages in TNBS-induced 
colonic inflammation. 
In summary, the protection from colitis observed in fat-1 and DHA-treated 
mice is associated with inhibition of NF-κB activation, down-regulation of 
COX-2 expression, activation of Nrf2 and up-regulation of HO-1 in the 
intestinal mucosa. Our present work provides the molecular mechanisms of 
anti-inflammatory and anti-oxidative activities of ω-3 PUFAs in the context of 









Sustained inflammation is a common denominator of the metabolic syndrome, 
and implicated in diverse pathological conditions and some types of human 
cancer. However, long-term use of the NSAIDs for the purpose of 
preventing/treating inflammation-associated chronic disorders is limited by 
side effects, so there is the need for new, effective and well-tolerated anti-
inflammatory agents. There has been a growing body of epidemiological, 
clinical and experimental evidence underscoring protective effects of dietary 
fish oil enriched with -3 PUFAs against pathogenesis of the aforementioned 
disorders. The pleiotropic effects of -3 PUFAs on multi-stage carcinogenesis 
and cancer progression are related to its ability to modulate inflammation-
associated signal transduction and gene expression. 
Interestingly, the use of fat-1 transgenic mice can eliminate the need of 
dietary manipulation and thereby avoid the potential confounding effects of 
dietary supplementation. This mouse model can provide a well-controlled 
experimental condition for studying the beneficial effects of -3 PUFAs. Thus, 
the transgenic mice provide powerful new tools for elucidating the benefits of 
-3 PUFAs and the molecular mechanisms of their action. 
Recent studies on the distinct set of metabolites derived from -3 PUFAs 
have revealed the endogenous formation of several novel lipid mediators which 
have proresolving as well as anti-inflammatory effects. If not resolved properly 
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and in a timely manner, inflammation becomes chronic and can cause various 
human diseases including cancer. In this regard, it’ll be worthwhile evaluating 
the chemopreventive and anti-carcinogenic potential of those proresolving as 
well as anti-inflammatory substances that originate from -3 PUFAs. 
Development of therapeutically relevant, stable synthetic analogues of -3 
PUFAs and their metabolites capable of activating proresolving signal 
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국 문 초 록 
 
염증과 암의 인과관계에 대한 많은 연구가 보고되고 있다. 
Cyclooxygenase-2 (COX-2)에 의해 생성되는 프로스타글란딘이 
염증반응을 매개하고, COX-2의 비정상적인 과도한 발현은 발암 
촉진 과정에서도 중요한 역할을 하는 것으로 알려져 왔다. 세포 내 
산화적 스트레스는 염증 반응 뿐만 아니라, 이를 스스로 제어하고 
조절하고자 하는 생체 내 방어기전을 유발한다. 이러한 세포의 
항산화 방어 기전에 중요한 역할을 하는 nuclear factor-erythroid 
related factor-2 (Nrf2)로, 이는 세포 내 다양한 스트레스에 의해 
활성화 되어, 항산화, 해독화 효소들의 발현을 촉진하는 전사인자로 
알려져 있다. 본 연구에서는 COX-2가 비정상적 과발현된 염증 및 
발암과정에서 화학암예방 후보물질로 알려진 오메가3 지방산이 
Nrf2의 활성화를 유도함으로써 산화적 스트레스 및 염증 상황을 
조절할 수 있는 지의 여부를 검토하고 그 작용 기전을 분자적 
수준에서 규명하고자 하였다. 
자외선은 피부노화와 광발암과정에 중요한 환경요인이다. 포유류 
피부에 자외선을 조사할 때 세포내 활성산소종의 증가하여 산화적 
스트레스가 유발되고, 이는 DNA손상, 단백질 불활성화, 유전자 
발현의 변형, 세포막의 손상 그리고 세포자살까지 이르게 한다. 본 
연구자는 오메가6 지방산들을 오메가3 지방산들로의 전환을 촉매 
하는 fat-1 유전자가 도입된 형질전환 마우스를 이용하여 자외선 
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B (Ultraviolet B; UVB)에 의한 피부 손상에 대한 오메가 3 
지방산의 보호 효과를 검토하였다. 상기 마우스에 오메가6 지방산이 
풍부한 식이를 공급하였을 때, Docosahexaenoic acid (DHA)를 
포함한 오메가3 지방산들이 피부 조직에 다량 생성되었다. 암컷 
wild-type (WT)과 fat-1 마우스 등에 UVB (500 mJ/cm2)를 
조사하였을 시, fat-1 마우스는 WT 마우스에 비해 UVB로 인한 
염증 및 산화적 조직 손상이 현저히 감소되어 있음을 관찰하였다. 
또한, UVB에 의한 signal transducer and activator of transcription 
3 (STAT3)의 활성화 및 이 전사 인자의 조절을 받는 표적 단백질 
COX-2의 발현이 경감된 것도 확인하였다. 자외선B 조사에 더 
민감한 피부 반응을 위해, fat-1 수컷과 무모 암컷 마우스들을 
교배하여 fat-1 무모 마우스들을 만들었다. 일주일에 3번, 23주 
동안 암컷 fat-1 무모 마우스 등에 UVB (180 mJ/cm2) 를 
조사하여 피부암을 유발시켰다. UVB는 WT의 무모 마우스에 
유의적으로 유두종 형성을 촉진하였으며 이는 fat-1 무모 
마우스에서 그 수가 감소하였다. 또한 피부염 모델 에서와 
마찬가지로 기존의 무모 마우스들에 비해 적은 양으로 염증 관련 
세포들이 피부에 침윤되었고, STAT3의 활성화와 COX-2의 발현도 
경감되었음을 알 수 있었다. 별도의 실험에서 기존의 WT 마우스와 
비교하였을 시, Nrf2 전사인자가 유도하는 hemeoxygenase-1 
(HO-1) 와  NAD(P)H quinoneoxidoreductase-1 (NQO1) 발현 
수준이 fat-1 마우스 피부 조직과 mouse embryonic fibroblast 
(MEF) 세포에서 증가되어 있음을 확인하였다. 마우스 상피 JB6 
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세포에 fat-1 유전자 과발현 벡터를 형질도입 하였을 때도 항산화 
효소들 발현이 확연히 증가되었다. fat-1 MEF 세포에 Nrf2 
siRNA를 형질도입 하였을 때, Nrf2 단백질 발현의 감소뿐 만 
아니라 세포보호단백질의 발현도 저해됨으로써, Nrf2가 fat-1 
유전자에 의한 HO-1과 NQO1 단백질 발현을 조절함을 알 수 
있었다. 이상의 연구결과들을 통해 자외선B가 유도하는 발암과정에 
대한 오메가3 지방산의 화학적암예방효과는 염증 및 발암 과정을 
매개하는 표적 단백질들의 활성화를 경감시키고, 활성산소종을 
제거하는 항산화 단백질들의 발현 증가를 통해 매개 된다고 
사료된다. 
장내 감염으로 인한 과민성 장 증후군이 염증 혹은 면역 
활성화의 결과로 다양한 소화 증상을 일으키고, 대장암 발생에 
영향을 주는 것으로 보고되고 있다. 2,4,6-Trinitrobenzene 
sulfonic acid (TNBS)는 장염 유발 약물로써 널리 사용되고 있으며 
과민반응에 의한 막내 염증을 유발한다. 막 투과를 원활하게 하기 
위해 에탄올에 녹여 마우스의 항문에 주입 시, TNBS가 장벽으로 
들어가 병변들을 유발하였지만, 이는 fat-1 형질전환 마우스에서 
경감되었다. 대표적인 오메가3 지방산인 DHA 처리시에도 fat-1 
형질전환 마우스의 경우와 마찬가지로 대장염에 대한 보호효과를 
관찰 할 수 있었다. 별도의 실험에서, 높은 비율의 오메가3 
지방산들의 생성과 DHA의 투여 시 TNBS에 의한 산화적 조직 
손상 및 염증 관련 효소 COX-2의 발현도 억제되었다. 한편 COX-
2 유전자 발현 조절에 중요한 역할을 하는 전사인자 nuclear 
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factor-kappa B (NF-κB)의 저해제 IκBα의 인산화 및 NF-κB의 
주요 구성성분 p65의 핵내 유입이 저해되었음을 관찰할 수 있었다. 
이러한 결과로부터 DHA를 포함한 오메가3 지방산의 마우스 
대장염 보호 효과는 TNBS에 의한 유도된 NF-κB 활성화 및 
COX-2 발현 억제를 통해 일어난다고 볼 수 있으며, 더 나아가 
대장암을 예방하는 효과를 나타낼 수 있음을 시사한다. 
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